Delaware |
7372 |
83-4599446 | ||
(State or other jurisdiction of incorporation or organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification No.) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Page |
||||
iii |
||||
1 |
||||
8 |
||||
47 |
||||
53 |
||||
54 |
||||
55 |
||||
56 |
||||
79 |
||||
114 |
||||
122 |
||||
140 |
||||
145 |
||||
147 |
||||
149 |
||||
155 |
||||
162 |
||||
164 |
||||
164 |
||||
165 |
||||
F-i |
• |
our ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition and the ability of the combined business to grow and manage growth profitably; |
• |
our future operating or financial results; |
• |
future acquisitions, business strategy and expected capital spending; |
• |
changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; |
• |
the implementation, market acceptance and success of our business model and growth strategy; |
• |
our expectations and forecasts with respect to the size and growth of the cybersecurity industry and our products and services in particular; |
• |
the ability of our products and services to meet customers’ compliance and regulatory needs; |
• |
our ability to compete with others in the cybersecurity industry; |
• |
our ability to retain pricing power with our products; |
• |
our ability to grow our market share; |
• |
our ability to attract and retain qualified employees and management; |
• |
our ability to adapt to changes in consumer preferences, perception and spending habits and develop and expand our product offerings and gain market acceptance of our products, including in new geographies; |
• |
developments and projections relating to our competitors and industry; |
• |
our ability to develop and maintain our brand and reputation; |
• |
developments and projections relating to our competitors and industry; |
• |
the impact of health epidemics, including the COVID-19 pandemic, on our business and on the economy in general; |
• |
the impact of the COVID-19 pandemic on customer demands for our products; |
• |
our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others; |
• |
expectations regarding the time during which we will be an emerging growth company under the JOBS Act; |
• |
our future capital requirements and sources and uses of cash; |
• |
our ability to obtain funding for our operations and future growth; and |
• |
our business, expansion plans and opportunities. |
• | We have experienced rapid growth in recent periods, and if the we do not manage our future growth, our business and results of operations will be adversely affected. |
• | We have a history of losses and we may not be able to achieve or sustain profitability in the future. |
• | If organizations do not adopt cloud-enabled, and/or SaaS-delivered cybersecurity solutions that may be based on new and untested security concepts, our ability to grow our business and results of operations may be adversely affected. |
• | Competition from existing or new companies could cause us to experience downward pressure on prices, fewer customer orders, reduced margins, the inability to take advantage of new business opportunities and loss of market share. |
• | If our solutions fail or are perceived to fail to detect or prevent incidents or have or are perceived to have defects, errors, or vulnerabilities, our brand and reputation would be harmed, which would adversely affect the our business and results of operations. |
• | We rely on third-party data centers and our own colocation data centers to host and operate our platform, and any disruption of or interference with its use of these facilities may negatively affect our ability to maintain the performance and reliability of our platform, which could cause our business to suffer. |
• | Our future success will be substantially dependent on our ability to attract, retain, and motivate the members of our management team and other key employees throughout our organization, and the loss of one or more key employees or an inability to attract and retain highly skilled employees could harm our business. |
• | If we are unable to maintain successful relationships with our distribution partners, or if our distribution partners fail to perform, our ability to market, sell and distribute our platform and solutions efficiently will be limited, and our business, financial position and results of operations will be harmed. |
• | Our business depends, in part, on sales to government organizations, and significant changes in the contracting or fiscal policies of such government organizations could have an adverse effect on our business and results of operations. |
• | The success of our business will depend in part on our ability to protect and enforce our intellectual property rights. |
• | We subject to laws and regulations, including governmental export and import controls, sanctions, and anti-corruption laws, that could impair our ability to compete in our markets and subject us to liability if we are not in full compliance with applicable laws. |
• | Our management has identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, which may result in material misstatements of our financial statements or cause us to fail to meet our periodic reporting obligations |
Shares of common stock offered by the Selling Stockholder |
Up to 48,503,325 shares (the “Purchase Shares”) we may sell to Tumim under the Purchase Agreement from time to time after the Commencement Date. |
Shares of common stock outstanding |
95,347,493 (as of March 7, 2022) |
Shares of common stock outstanding after giving effect to the issuance of the shares registered hereunder |
143,850,818 (based on the total shares outstanding as of March 7, 2022) |
Use of proceeds |
We will not receive any proceeds from the sale of shares of common stock included in this prospectus by the Selling Stockholder. We may receive up to $175 million aggregate gross proceeds under the Purchase Agreement from sales of common stock that we elect to make to Tumim pursuant to the Purchase Agreement, if any, from time to time in our sole discretion, from and after the Commencement Date. |
Risk factors |
See the section titled “Risk Factors” and the other information included in this prospectus for a discussion of factors you should consider carefully before deciding to invest in our common stock. |
NYSE ticker symbols |
“IRNT” |
• | 4,462,905 shares of common stock issuable upon the settlement of restricted stock units (“RSUs”) granted under the 2021 Equity Incentive Plan (the “2021 Plan”); |
• | 13,971,064 shares of common stock available for future issuance under the 2021 Plan; |
• | 1,317,178 shares of common stock issuable upon the exercise of outstanding options granted under the 2014 Stock Incentive Plan (the “2014 Plan”); |
• | 9,920,389 shares underlying RSUs granted pursuant to the 2014 Plan; |
• | 3,588,763 shares available for future issuance under our 2021 Employee Stock Purchase Plan (the “ESPP”); |
• | 9,500 shares issuable upon the exercise of outstanding private warrants to purchase common stock (the “Private Warrants”), with an exercise price of $11.50 per share; and |
• | 8,606,473 shares issuable upon the exercise of outstanding public warrants to purchase common stock, (the “Public Warrants,” together with the Private Warrants the “Warrants”) with an exercise price of $11.50 per share. |
• | effectively attract, integrate and retain a large number of new employees, particularly members of our sales and marketing, data science, and research and development teams; |
• | further improve our platform and products, including our cloud modules and security capabilities, analytics, collective defense capabilities, and visualizations, and IT infrastructure, including expanding and optimizing our data centers, collection, and analytic capabilities, to support our business needs; |
• | enhance our information and communication systems to ensure that our employees and offices around the world are well coordinated and can effectively communicate with each other and our growing base of customers and partners; and |
• | improve our financial, management, and compliance systems and controls. |
• | product capabilities, including performance and reliability, of our platform, including our services and features particularly in the areas of analytics and collective defense, compared to those of our competitors; |
• | our ability, and the ability of our competitors, to improve existing products, services and features, or to develop new ones to address evolving customer needs; |
• | our ability to attract, retain and motivate talented employees; |
• | our ability to establish, capitalize on, maintain, and grow relationships with distribution and technology partners; |
• | the strength of our sales and marketing efforts; and |
• | acquisitions or consolidation within our industry, which may result in more formidable competitors. |
• | First generation Network Detection and Response (NDR) vendors such as DarkTrace or Vectra Networks, who offer point products based on Bayesian analysis, outlier analysis, and heuristic detection-based detection; |
• | Network security vendors, such as Cisco and Palo Alto Networks, Inc., who are supplementing their core network security additional behavioral-based detection with behavioral-based detection, threat intelligence and security operations solutions; and |
• | Legacy network infrastructure and performance monitoring companies such as ExtraHop and Arista Networks, who are adding security use cases to their infrastructure products. |
• | the development and maintenance of the infrastructure of the internet; |
• | the performance and availability of third-party providers of cloud infrastructure services with the necessary speed, data capacity, and security for providing reliable internet access and services; |
• | decisions by the owners and operators of the data centers where our cloud infrastructure is deployed to terminate our contracts, discontinue services, shut down operations or facilities, increase prices, change service levels, limit bandwidth, declare bankruptcy or prioritize the traffic of other parties; |
• | physical or electronic break-ins, acts of war or terrorism, human error or interference (including by disgruntled employees, former employees or contractors) and other catastrophic events; |
• | cyberattacks, including denial of service attacks, targeted at us, our data centers, or the infrastructure of the internet; |
• | failure by us to maintain and update our cloud infrastructure to meet our data capacity requirements; |
• | errors, defects, or performance problems in our software, including third-party or open-source software incorporated in our software; |
• | improper deployment or configuration of our solutions; |
• | the failure of its redundancy systems, in the event of a service disruption at one of our data centers, to provide failover to other data centers in our data center network; |
• | the failure of our disaster recovery and business continuity arrangements; and |
• | effects of third-party software updates with hidden malware, similar to the supply chain attack that occurred via SolarWinds. |
Year Ended January 31, |
||||||||
2021 |
2020 |
|||||||
Customer A |
10 | % | * | |||||
Customer B |
* | 14 | % | |||||
Customer C |
* | 10 | % | |||||
Customer D |
* | 10 | % | |||||
Customer E |
* | 14 | % |
* | Less than 10% |
Nine Months Ended October 31, |
||||||||
2021 |
2020 |
|||||||
Customer A |
11 | % | * | |||||
Customer B |
11 | % | * | |||||
Customer C |
* | 10 | % | |||||
|
|
|
|
|||||
22 | % | 10 | % |
* | Less than 10% |
• | the impact of the COVID-19 pandemic, including the emergence of variant strains of COVID-19, on our operations, financial results, and liquidity and capital resources, including on customers, sales, expenses, and employees; |
• | our ability to attract new and retain existing customers; |
• | the budgeting cycles, seasonal buying patterns, and purchasing practices of customers; |
• | the timing and length of our sales cycles; |
• | changes in customer or distribution partner requirements or market needs; |
• | changes in the growth rate of our market; |
• | the timing and success of new product and service introductions by us or our competitors or any other competitive developments, including consolidation among our customers or competitors; |
• | the level of awareness of cybersecurity threats, particularly advanced cyberattacks, and the market adoption of our platform; |
• | our ability to successfully expand our business domestically and internationally; |
• | decisions by organizations to purchase security solutions from larger, more established security vendors or from their primary IT equipment vendors; |
• | changes in our pricing policies or those of our competitors; |
• | any disruption in our relationship with distribution partners; |
• | insolvency or credit difficulties confronting our customers, affecting their ability to purchase or pay for our solutions; |
• | significant security breaches of, technical difficulties with or interruptions to, the use of our platform; |
• | extraordinary expenses such as litigation or other dispute-related settlement payments or outcomes; |
• | rising inflation and our ability to control costs, including our operating expenses; |
• | general economic conditions, both in domestic and foreign markets; |
• | future accounting pronouncements or changes in our accounting policies or practices; |
• | negative media coverage or publicity; |
• | political events; |
• | the amount and timing of operating costs and capital expenditures related to the expansion of our business; and |
• | increases or decreases in expenses caused by fluctuations in foreign currency exchange rates. |
• | selling to governmental agencies can be highly competitive, expensive and time-consuming, often requiring significant upfront time and expense without any assurance that such efforts will generate a sale; |
• | government certification requirements applicable to our products may change and, in doing so, restrict our ability to sell into the U.S. federal government sector until it has attained the required certifications. |
• | government demand and payment for our platform may be impacted by public sector budgetary cycles and funding authorizations, with funding reductions or delays adversely affecting public sector demand for our platform; |
• | governments routinely investigate and audit government contractors’ administrative processes, and any unfavorable audit could result in the government refusing to continue buying our platform, which would adversely impact our revenue and results of operations, or institute fines or civil or criminal liability if the audit were to uncover improper or illegal activities; |
• | interactions with the U.S. federal government may be limited by post-employment ethics restrictions on members of our management; |
• | foreign governments may have concerns with purchasing security products from a company that employs former NSA employees and officials, which may negatively impact sales; and |
• | governments may require certain products to be manufactured, hosted, or accessed solely in their country or in other relatively high-cost manufacturing locations, and we may not manufacture all products in locations that meet these requirements, affecting its ability to sell these products to governmental agencies. |
• | investigations, enforcement actions and sanctions; |
• | mandatory changes to our platform; |
• | disgorgement of profits, fines and damages; |
• | civil and criminal penalties or injunctions; |
• | claims for damages by its customers or distribution partners; |
• | termination of contracts; |
• | loss of intellectual property rights; and |
• | temporary or permanent debarment from sales to government organizations. |
• | resulting in time-consuming and costly litigation; |
• | diverting management’s time and attention from developing our business; |
• | requiring us to pay monetary damages or enter into royalty and licensing agreements that we would not normally find acceptable; |
• | causing delays in the deployment of its platform or service offerings to our customers; |
• | requiring us to stop offering certain services or features of our platform; |
• | requiring us to redesign certain components of our platform using alternative non-infringing or non-open source technology, which could require significant effort and expense; |
• | requiring us to disclose its software source code and the detailed program commands for our software; |
• | prohibiting us from charging license fees for the proprietary software that uses certain open source; and |
• | requiring us to satisfy indemnification obligations to our customers. |
• | diversion of management time and focus from operating our business to addressing acquisition integration challenges; |
• | coordination of engineering, analytics, research and development, operations, and sales and marketing functions; |
• | integration of product and service offerings; |
• | retention of key employees from the acquired company; |
• | changes in relationships with strategic partners as a result of product acquisitions or strategic positioning resulting from the acquisition; |
• | cultural challenges associated with integrating employees from the acquired company into the organization; |
• | integration of the acquired company’s accounting, management information, human resources and other administrative systems; |
• | the need to implement or improve controls, procedures, and policies at a business that prior to the acquisition may have lacked sufficiently effective controls, procedures and policies; |
• | financial reporting, revenue recognition or other financial or control deficiencies of the acquired company that are not adequately addressed and that cause our reported results to be incorrect; |
• | liability for activities of the acquired company before the acquisition, including intellectual property infringement claims, violations of laws, commercial disputes, tax liabilities and other known and unknown liabilities; |
• | unanticipated write-offs or charges; and |
• | litigation or other claims in connection with the acquired company, including claims from terminated employees, customers, former stockholders or other third parties. |
• | greater difficulty in negotiating contracts with standard terms, enforcing contracts, and managing collections, including longer collection periods; |
• | higher costs of doing business internationally, including costs incurred in establishing and maintaining office space and equipment for international operations and creating international operating entities, where applicable; |
• | management communication and integration problems resulting from cultural and geographic dispersion; |
• | risks associated with trade restrictions and foreign legal requirements, including any importation, certification, and localization of our platform that may be required in foreign countries; |
• | greater risk of unexpected changes in applicable foreign laws, regulatory practices, tariffs, and tax laws and treaties; |
• | compliance with anti-bribery laws, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. Travel Act and the UK Bribery Act 2010, violations of which could lead to significant fines, penalties, and collateral consequences; |
• | heightened risk of unfair or corrupt business practices in certain geographies and of improper or fraudulent sales arrangements that may impact financial results and result in restatements of, or irregularities in, financial statements; |
• | the uncertainty of protection for intellectual property rights in some countries; |
• | general economic and political conditions in these foreign markets; |
• | foreign exchange controls or tax regulations that might prevent us from repatriating cash earned outside the United States; |
• | political and economic instability in some countries; |
• | the potential for foreign government demands for access to information or corporate property; |
• | double taxation of international earnings and potentially adverse tax consequences due to changes in the tax laws of the United States or the foreign jurisdictions in which we operate; |
• | unexpected costs for the localization of services, including translation into foreign languages and adaptation for local practices and regulatory requirements; |
• | requirements to comply with foreign privacy, data protection, and information security laws and regulations and the risks and costs of noncompliance; |
• | greater difficulty in identifying, attracting and retaining local qualified personnel, and the costs and expenses associated with such activities; |
• | greater difficulty identifying qualified distribution partners and maintaining successful relationships with such partners; |
• | differing employment practices and labor relations issues; and |
• | difficulties in managing and staffing international offices and increased travel, infrastructure, and legal compliance costs associated with multiple international locations. |
• | threatened or actual litigation or government investigations; |
• | the occurrence of severe weather conditions and other catastrophes; |
• | our operating and financial performance, quarterly or annual earnings relative to similar companies; |
• | publication of research reports or news stories about us, our competitors or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts; |
• | the public’s reaction to our press releases, our other public announcements and our filings with the SEC; |
• | announcements by us or our competitors of acquisitions, business plans or commercial relationships; |
• | any major change in our board of directors or senior management; |
• | additional sales of our securities by us, our directors, executive officers or principal stockholders; |
• | adverse market reaction to any indebtedness we may incur or securities we may issue in the future; |
• | short sales, hedging and other derivative transactions in our securities; |
• | exposure to capital market risks related to changes in interest rates, realized investment losses, credit spreads, equity prices, foreign exchange rates and performance of insurance linked investments; |
• | our creditworthiness, financial condition, performance, and prospects; |
• | our dividend policy and whether dividends on our common stock have been, and are likely to be, declared and paid from time to time; |
• | perceptions of the investment opportunity associated with our securities relative to other investment alternatives; |
• | regulatory or legal developments; |
• | changes in general market, economic, and political conditions; |
• | conditions or trends in our industry, geographies or customers; and |
• | changes in accounting standards, policies, guidance, interpretations or principles. |
• | limited availability of market quotations for our securities; |
• | a determination that our common stock is a “penny stock” which will require brokers trading in our common stock to adhere to more stringent rules, |
• | possibly resulting in a reduced level of trading activity in the secondary trading market for shares of our common stock; |
• | a limited amount of analyst coverage; and |
• | a decreased ability to issue additional securities or obtain additional financing in the future. |
• | existing stockholders’ proportionate ownership interest in our company will decrease; |
• | the amount of cash available per share, including for payment of dividends in the future, may decrease; |
• | the relative voting strength of each share of previously outstanding common stock may be diminished; and |
• | the market price of our common stock may decline. |
• | the division of the Board into three classes and the election of each class for three-year terms; |
• | advance notice requirements for stockholder proposals and director nominations; |
• | provisions limiting stockholders’ ability to call special meetings of stockholders, to require special meetings of stockholders to be called, and to take action by written consent; |
• | restrictions on business combinations with interested stockholders; |
• | in certain cases, the approval of holders representing at least 66 2/3% of the total voting power of the shares entitled to vote generally in the election of directors will be required for stockholders to adopt, amend or repeal the bylaws, or amend or repeal certain provisions of the Charter; |
• | no cumulative voting; and |
• | the ability of the Board to designate the terms of and issue new series of preferred stock without stockholder approval, which could be used, among other things, to institute a rights plan that would have the effect of significantly diluting the stock ownership of a potential hostile acquirer, likely preventing acquisitions by such acquirer. |
• | (i) the product obtained by multiplying (A) the average daily trading volume in the common stock on the NYSE during the five trading days immediately preceding the applicable day Tumim receives a valid Purchase notice for such Purchase and (B) 0.20, and (ii) the quotient obtained by dividing (A) $20,000,000 by (B) the VWAP of the common stock on the NYSE on the trading day immediately preceding the applicable day Tumim receives a valid Purchase notice for such Purchase, with respect to any VWAP Purchase that is designated as a “Forward VWAP Purchase”; or |
• | (i) the product obtained by multiplying (A) the average daily trading volume in the common stock on the NYSE during the five trading days immediately preceding the applicable day Tumim receives a valid Purchase notice for such Purchase and (B) 0.40, and (ii) the quotient obtained by dividing (A) $30,000,000 by (B) the VWAP of the common stock on the NYSE on the trading day immediately preceding the applicable day Tumim receives a valid Purchase notice for such Purchase, with respect to any VWAP Purchase that is designated as a “Alternative VWAP Purchase”. |
• | the accuracy in all material respects of our representations and warranties included in the Purchase Agreement; |
• | us having performed, satisfied and complied in all material respects with all covenants, agreements and conditions required by the Purchase Agreement to be performed, satisfied or complied with by us; |
• | the effectiveness of this registration statement that includes this prospectus (and any one or more additional registration statements filed with the SEC that include shares of common stock that may be issued and sold by us to Tumim under the Purchase Agreement); |
• | the SEC shall not have issued any stop order suspending the effectiveness, prohibiting or suspending the use of the registration statement that includes this prospectus (or any one or more additional registration statements filed with the SEC that include shares of common stock that may be issued and sold by us to Tumim under the Purchase Agreement); |
• | there shall not have occurred any event and there shall not exist any condition or state of facts, which makes any statement of a material fact made in the registration statement that includes this prospectus (or in any one or more additional registration statements filed with the SEC that include shares of common stock that may be issued and sold by us to Tumim under the Purchase Agreement) untrue or which requires the making of any additions to or changes to the statements contained therein in order to state a material fact required by the Securities Act to be stated therein or necessary in order to make the statements then made therein (in the case of this prospectus or the prospectus included in any one or more additional registration statements filed with the SEC under the Registration Rights Agreement, in light of the circumstances under which they were made) not misleading; |
• | this prospectus, in final form, shall have been filed with the SEC under the Securities Act, and all reports, schedules, registrations, forms, statements, information and other documents required to have been filed by the Company with the SEC pursuant to the reporting requirements of the Exchange Act, shall have been filed with the SEC; |
• | trading in our common stock shall not have been suspended by the SEC or the NYSE, we shall not have received any final and non-appealable notice that the listing or quotation of the common stock on the NYSE shall be terminated on a date certain (unless, prior to such date, the common stock is listed or quoted on the NYSE, The Nasdaq Global Market, The Nasdaq Global Select Market the the NYSE American, or the NYSE Arca (or any nationally recognized successor to any of the foregoing) (each, an “Eligible Market”)), and there shall be no suspension of, or restriction on, accepting additional deposits of the common stock, electronic trading or book-entry services by DTC with respect to the common stock; |
• | we shall have complied with all applicable federal, state and local governmental laws, rules, regulations and ordinances in connection with the execution, delivery and performance of the Purchase Agreement and the Registration Rights Agreement; |
• | the absence of any statute, regulation, order, decree, writ, ruling or injunction by any court or governmental authority of competent jurisdiction which prohibits the consummation of or that would materially modify or delay any of the transactions contemplated by the Purchase Agreement or the Registration Rights Agreement; |
• | the absence of any action, suit or proceeding before any arbitrator or any court or governmental authority seeking to restrain, prevent or change the transactions contemplated by the Purchase Agreement or the Registration Rights Agreement, or seeking material damages in connection with such transactions; |
• | all of the shares of common stock that may be issued pursuant to the Purchase Agreement shall have been approved for listing or quotation on the NYSE (or if the common stock is not then listed on the NYSE, on any Eligible Market); |
• | no condition, occurrence, state of facts or event constituting a material adverse effect shall have occurred and be continuing; |
• | any voluntary or involuntary participation or threatened participation in insolvency or bankruptcy proceedings by or against us; and |
• | the receipt by Tumim of the opinions, bring-down opinions and negative assurances from outside counsel to us in the forms mutually agreed to by us and Tumim prior to the date of the Purchase Agreement. |
• | the first day of the month next following the 36-month anniversary of the Commencement Date; |
• | the date on which Tumim shall have purchased shares of common stock under the Purchase Agreement for an aggregate gross purchase price equal to its $175 million Total Commitment under the Purchase Agreement; |
• | the date on which the common stock shall have failed to be listed or quoted on the NYSE or any other Eligible Market; and |
• | the date on which we commence a voluntary bankruptcy case or any third party commences a bankruptcy proceeding against us, a custodian is appointed for us in a bankruptcy proceeding for all or substantially all of its property, or we make a general assignment for the benefit of its creditors. |
• | the occurrence of a Material Adverse Effect (as defined in the Purchase Agreement); |
• | the occurrence of a Fundamental Transaction (as defined in the Purchase Agreement) involving us; |
• | our failure to file with the SEC or have declared effective by the SEC the registration statement that includes this prospectus or any additional registration statement we file with the SEC pursuant to the Registration Rights Agreement, within the time periods set forth in the Registration Rights Agreement or our breach or default of the Registration Rights Agreement; |
• | the effectiveness of the registration statement that includes this prospectus or any additional registration statement we file with the SEC pursuant to the Registration Rights Agreement lapses for any reason (including the issuance of a stop order by the SEC), or this prospectus or the prospectus included in any additional registration statement we file with the SEC pursuant to the Registration Rights Agreement otherwise becomes unavailable to Tumim for the resale of all of the shares of common stock included therein, and such lapse or unavailability continues for a period of 30 consecutive trading days or for more than an aggregate of 120 trading days in any 365-day period, other than due to acts of Tumim; |
• | trading in the common stock on the NYSE (or if the common stock is then listed on an Eligible Market, trading in the common stock on such Eligible Market) has been suspended for a period of three consecutive trading days; or |
• | our material breach or default under the Purchase Agreement. |
Assumed Average Purchase Price Per Share |
Number of Registered Shares to be Issued if Full Purchase (1) |
Percentage of Outstanding Shares After Giving Effect to the Issuance to Tumim (2) |
Gross Proceeds from the Sale of Shares to Tumim Under the Purchase Agreement |
|||||||||
$3.00 |
48,503,325 | 34 | % | $ | 145,509,975 | |||||||
$3.608 (3) |
48,503,325 | 34 | % | $ | 174,999,997 | |||||||
$4.76 (4) |
36,764,706 | 28 | % | $ | 175,000,000 | |||||||
$5.00 |
35,000,000 | 27 | % | $ | 175,000,000 | |||||||
$7.00 |
25,000,000 | 21 | % | $ | 175,000,000 |
(1) | Although the Purchase Agreement provides that we may sell up to $175 million of our common stock to Tumim, we are only registering 48,503,325 shares under this prospectus which represents shares which may be issued to Tumim in the future under the Purchase Agreement, if and when we sell shares to Tumim under the Purchase Agreement, and which may or may not cover all the shares we ultimately sell to Tumim under the Purchase Agreement, depending on the purchase price per share. As a result, we have included in this column only those shares that we are registering in this offering, without regard to the Beneficial Ownership Cap or the Exchange Cap. If we seek to issue shares of our common stock, including shares from other transactions that may be aggregated with the transactions contemplated by the Purchase Agreement under the applicable rules of the NYSE, in excess of 17,743,727 shares, or 19.99% of the total common stock outstanding immediately prior to the execution of the Purchase Agreement, we may be required to seek stockholder approval in order to be in compliance with the rules of the NYSE. The assumed average purchase prices per share are solely for illustrative purposes and are not intended to be estimates or predictions of the future performance of our common stock. |
(2) | The denominator is based on 95,347,493 shares outstanding as of March 7, 2022. The numerator is based on the number of shares issuable under the Purchase Agreement at the corresponding assumed purchase price set forth in the first column. |
(3) | The NYSE base price. |
(4) | The closing sale price of our common stock on March 8, 2022. |
• | continue to invest in research and development related to new technologies; |
• | increase our investment in marketing and advertising, as well as the sales and distribution infrastructure for our products and services; |
• | maintain and improve operational, financial, and management information systems; |
• | hire additional personnel; |
• | obtain, maintain, expand, and protect our intellectual property portfolio; and |
• | enhance internal functions to support our operations as a publicly-traded company. |
October 31, |
||||||||
2021 |
2020 |
|||||||
Recurring Software Customers |
74 | 25 | ||||||
Year-over-year growth |
196 | % | 47 | % |
January 31, |
||||||||
2021 |
2020 |
|||||||
Recurring Software Customers |
27 | 20 | ||||||
Year-over-year growth |
35 | % | 43 | % |
October 31, |
||||||||
2021 |
2020 |
|||||||
(in millions) | ||||||||
Annual recurring revenues |
$ | 27.5 | $ | 21.2 | ||||
Year-over-year growth |
30 | % | 32 | % |
January 31, |
||||||||
2021 |
2020 |
|||||||
(in millions) | ||||||||
Annual recurring revenues |
$ | 25.8 | $ | 15.0 | ||||
Year-over-year growth |
72 | % | 37 | % |
• | Numerator: We multiply the average total length of the contracts, measured in years or fractions thereof, by the respective revenue recognized for the applicable reporting period. |
• | Denominator: We use the revenue attributable to software and product customers for the same period used in the numerator. This effectively represents the revenue base that is being generated by those customers. |
October 31, |
||||||||
2021 |
2020 |
|||||||
(in years) | ||||||||
Dollar-based average contract length |
2.8 | 3.2 |
January 31, |
||||||||
2021 |
2020 |
|||||||
(in years) | ||||||||
Dollar-based average contract length |
2.9 | 3.5 |
Three Months Ended October 31, |
||||||||||||||||
2021 |
2020 |
2021 vs 2020 |
||||||||||||||
($in millions) |
||||||||||||||||
Revenue |
$ | 6.9 | $ | 7.0 | (0.1 | ) | (1 | )% | ||||||||
Add: Total Deferred revenue, end of period |
30.1 | 23.0 | 7.1 | 31 | ||||||||||||
Less: Total Deferred revenue, beginning of period |
33.6 | 21.9 | 11.7 | 53 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Calculated billings |
$ | 3.4 | $ | 8.1 | (4.7 | ) | (58 | )% | ||||||||
|
|
|
|
|
|
|
|
Nine Months Ended October 31, |
||||||||||||||||
2021 |
2020 |
2021 vs 2020 |
||||||||||||||
($in millions) |
||||||||||||||||
Revenue |
$ | 19.4 | $ | 21.8 | (2.4 | ) | (11 | )% | ||||||||
Add: Total Deferred revenue, end of period |
30.1 | 23.0 | 7.1 | 31 | ||||||||||||
Less: Total Deferred revenue, beginning of period |
34.0 | 20.3 | 13.7 | 67 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Calculated billings |
$ | 15.5 | $ | 24.5 | (9.0 | ) | (37 | )% | ||||||||
|
|
|
|
|
|
|
|
Three Months Ended October 31, |
Nine Months Ended October 31, |
|||||||
2021 |
2021 |
|||||||
($in thousands) |
||||||||
Net loss |
$ | (193,122 | ) | $ | (225,789 | ) | ||
Stock compensation expense (1) |
160,094 | 160,094 | ||||||
Change in fair value of warrants liabilities |
11,302 | 11,302 | ||||||
Transaction costs expense (2) |
1,556 | 2,328 | ||||||
|
|
|
|
|||||
Non-GAAP Adjusted Net Loss |
$ | (20,170 | ) | $ | (52,065 | ) |
1. | Total stock based compensation of $160.1 million has been recorded within research and development of $20.9 million, sales and marketing of $49.3 million, and general and administrative expense of $89.9 million on the statement of operations |
2. | Transaction expenses have been recorded within general and administrative expense on the statement of operations |
Three Months Ended October 31, |
||||||||||||||||
2021 |
2020 |
Change $ |
Change% |
|||||||||||||
($ in thousands) | ||||||||||||||||
Product, subscription and support revenue |
$ | 6,132 | $ | 5,958 | $ | 174 | 3 | % | ||||||||
Professional services revenue |
781 | 1,055 | (274 | ) | (26 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total revenue |
6,913 | 7,013 | (100 | ) | (1 | )% | ||||||||||
Cost of product, subscription and support revenue |
2,082 | 1,252 | 830 | 66 | % | |||||||||||
Cost of professional services revenue |
286 | 817 | (531 | ) | (65 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cost of revenue |
2,368 | 2,069 | 299 | 14 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit |
4,545 | 4,944 | (399 | ) | (8 | )% | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating expenses |
||||||||||||||||
Research and development |
28,144 | 5,687 | 22,457 | 395 | % | |||||||||||
Sales and marketing |
57,196 | 7,155 | 50,041 | 699 | % | |||||||||||
General and administrative |
100,267 | 4,715 | 95,552 | 2,027 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses |
185,607 | 17,557 | 168,050 | 957 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Operating loss |
(181,062 | ) | (12,613 | ) | (168,449 | ) | 1,336 | % | ||||||||
Other (expense) income, net |
(724 | ) | 178 | (902 | ) | (507 | )% | |||||||||
|
|
|
|
|
|
|
|
|||||||||
Change in fair value of warrants liabilities |
(11,302 | ) | — | (11,302 | ) | 100 | % | |||||||||
Loss before income taxes |
(193,088 | ) | (12,435 | ) | (180,653 | ) | 1,453 | % | ||||||||
Benefit (provision) for income taxes |
(34 | ) | (19 | ) | (15 | ) | 79 | % | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss |
$ | (193,122 | ) | $ | (12,454 | ) | $ | (180,668 | ) | 1,451 | % | |||||
|
|
|
|
|
|
|
|
Three Months Ended October 31, |
|
|
||||||||||||||
2021 |
2020 |
Change $ |
Change% |
|||||||||||||
($ in millions) | ||||||||||||||||
Product, subscription and support gross profit |
$ | 4.0 | $ | 4.7 | $ | (0.7 | ) | (15 | )% | |||||||
Professional services gross profit |
0.5 | 0.2 | 0.3 | 150 | % | |||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total gross profit |
$ | 4.5 | $ | 4.9 | $ | (0.4 | ) | (8 | )% | |||||||
|
|
|
|
|
|
|
|
2021 |
2020 |
Change |
||||||||||
Product, subscription and support margin |
66.0 | % | 79.0 | % | (13.0 | )% | ||||||
Professional services margin |
63.4 | % | 22.6 | % | 40.8 | % | ||||||
|
|
|
|
|
|
|||||||
Total gross margin |
65.7 | % | 70.5 | % | (4.8 | )% |
Nine Months Ended October 31, |
||||||||||||||||
2021 |
2020 |
Change $ |
Change % |
|||||||||||||
($ in thousands) | ||||||||||||||||
Product, subscription and support revenue |
$ | 18,038 | $ | 18,047 | $ | (9 | ) | (0 | )% | |||||||
Professional services revenue |
1,327 | 3,779 | (2,452 | ) | (65 | )% | ||||||||||
Total revenue |
19,365 | 21,826 | (2,461 | ) | (11 | )% | ||||||||||
Cost of product, subscription and support revenue |
5,505 | 3,534 | 1,971 | 56 | % | |||||||||||
Cost of professional services revenue |
617 | 1,596 | (979 | ) | (61 | )% | ||||||||||
Total cost of revenue |
6,122 | 5,130 | 992 | 19 | % | |||||||||||
Gross profit |
13,243 | 16,696 | (3,453 | ) | (21 | )% | ||||||||||
Operating expenses |
||||||||||||||||
Research and development |
42,606 | 19,965 | 22,641 | 113 | % | |||||||||||
Sales and marketing |
72,046 | 23,265 | 48,781 | 210 | % | |||||||||||
General and administrative |
111,952 | 16,690 | 95,262 | 571 | % | |||||||||||
Total operating expenses |
226,604 | 59,920 | 166,684 | 278 | % | |||||||||||
Operating loss |
(213,361 | ) | (43,224 | ) | (170,137 | ) | 394 | % | ||||||||
Other (expense) income, net |
(1,070 | ) | 125 | (1,195 | ) | (956 | )% | |||||||||
Change in fair value of warrants liabilities |
(11,302 | ) | — | (11,302 | ) | 100 | % | |||||||||
Loss before income taxes |
(225,733 | ) | (43,099 | ) | (182,634 | ) | 424 | % | ||||||||
Benefit (provision) for income taxes |
(56 | ) | (58 | ) | 2 | (3 | )% | |||||||||
Net loss |
$ | (225,789 | ) | $ | (43,157 | ) | $ | (182,632 | ) | 423 | % |
Nine Months Ended October 31, |
||||||||||||||||
2021 |
2020 |
Change $ |
Change % |
|||||||||||||
($ in thousands) | ||||||||||||||||
Product, subscription and support gross profit |
$ | 12.5 | $ | 14.5 | $ | (2.0 | ) | (14 | )% | |||||||
Professional services profit |
0.7 | 2.2 | (1.5 | ) | (68 | )% | ||||||||||
Total gross profit |
$ | 13.2 | $ | 16.7 | $ | (3.5 | ) | (21 | )% |
2021 |
2020 |
Change |
||||||||||
Product, subscription and support margin |
69.5 | % | 80.4 | % | (10.9 | )% | ||||||
Professional services margin |
53.5 | % | 57.8 | % | (4.3 | )% | ||||||
Total gross margin |
68.4 | % | 76.5 | % | (8.1 | )% |
Year Ended January 31, |
||||||||||||||||||||||||
2021 |
2020 |
2021 vs 2020 |
||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||
Products, subscription and support revenue |
$ | 24.7 | 85 | % | $ | 19.8 | 85 | % | $ | 4.9 | 25 | % | ||||||||||||
Professional services revenue |
4.5 | 15 | % | 3.4 | 15 | % | 1.1 | 32 | % | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Total revenue |
29.2 | 100 | % | 23.2 | 100 | % | 6.0 | 26 | % | |||||||||||||||
Cost of product, subscription and support revenue |
5.4 | 18 | % | 5.9 | 25 | % | (0.5 | ) | -8 | % | ||||||||||||||
Cost of professional service revenue |
1.6 | 5 | % | 0.7 | 3 | % | 0.9 | 129 | % | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Total cost of revenue |
7.0 | 24 | % | 6.6 | 29 | % | 0.4 | 6 | % | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Gross profit |
22.2 | 76 | % | 16.6 | 72 | % | 5.6 | 34 | % | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Research and development |
25.8 | 88 | % | 26.6 | 115 | % | (0.8 | ) | -3 | % | ||||||||||||||
Sales and marketing |
30.4 | 104 | % | 17.9 | 77 | % | 12.5 | 70 | % | |||||||||||||||
General and administrative |
21.3 | 73 | % | 20.5 | 88 | % | 0.8 | 4 | % | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Total operating expenses |
77.5 | 265 | % | 65.0 | 280 | % | 12.5 | 19 | % | |||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Operating loss |
(55.3 | ) | -189 | % | (48.4 | ) | -209 | % | (6.9 | ) | 14 | % | ||||||||||||
Other income, net |
(0.0 | ) | 0 | % | 0.5 | 2 | % | (0.5 | ) | -100 | % | |||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Loss before provision for income taxes |
(55.3 | ) | -189 | % | (47.9 | ) | -206 | % | (7.4 | ) | 15 | % | ||||||||||||
Provision for income taxes |
(0.1 | ) | 0 | % | (0.0 | ) | 0 | % | (0.1 | ) | nm | |||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Net loss |
$ | (55.4 | ) | -190 | % | $ | (47.9 | ) | -206 | % | $ | (7.5 | ) | 16 | % | |||||||||
|
|
|
|
|
|
Year Ended January 31, |
||||||||||||||||
2021 |
2020 |
2021 vs 2020 |
||||||||||||||
(in millions) | ||||||||||||||||
Software products margin |
$ | 19.3 | $ | 13.9 | $ | 5.4 | 39 | % | ||||||||
Professional services margin |
2.9 | 2.6 | 0.3 | 12 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total Gross profit margin |
$ | 22.2 | $ | 16.5 | $ | 5.7 | 35 | % | ||||||||
|
|
|
|
|
|
|||||||||||
2021 |
2020 |
Change |
||||||||||||||
Software products margin |
78.1 | % | 70.2 | % | 7.9 | % | ||||||||||
Professional services margin |
64.4 | % | 79.4 | % | -15.0 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Total Gross profit margin |
76.0 | % | 71.6 | % | 4.4 | % |
Nine Months Ended October 31, |
||||||||
2021 |
2020 |
|||||||
(in thousands) |
||||||||
Net cash used in operating activities |
$ | (59,095 | ) | $ | (39,897 | ) | ||
Net cash (used in) provided by investing activities |
$ | (2,156 | ) | $ | 1,057 | |||
Net cash provided by financing activities |
$ | 103,381 | $ | 49,707 |
Year Ended January 31, |
||||||||
2021 |
2020 |
|||||||
(in millions) | ||||||||
Net cash used in operating activities |
$ | (42.7 | ) | $ | (48.8 | ) | ||
Net cash provided by investing activities |
$ | 0.1 | $ | 24.2 | ||||
Net cash provided by financing activities |
$ | 63.3 | $ | 10.7 |
• | Identification of the contract, or contracts, with a customer |
goods or services, (ii) the contract has commercial substance and the parties are committed to perform, and (iii) we determine that collection of substantially all consideration to which we will be entitled in exchange for goods or services that will be transferred is probable based on the customer’s intent and ability to pay the promised consideration. |
• | Identification of the performance obligations in the contract |
• | Determination of the transaction price |
• | Allocation of the transaction price to the performance obligations in the contract |
• | Recognition of revenue when, or as, we satisfy performance obligations |
• | We did not design and maintain effective controls over the review of journal entries and account reconciliations. Specifically, certain personnel have the ability to both (i) create and post journal entries within our general ledger system, and (ii) prepare and review account reconciliations. |
• | We did not design and maintain effective controls over information technology general controls for information systems that are relevant to the preparation of our financial statements. Specifically, we did not design and maintain: (i) program change management controls for the financial systems to ensure that information technology program and data changes affecting financial IT applications and underlying accounting records are identified, tested, authorized and implemented appropriately; |
(ii) appropriate user access controls to ensure appropriate segregation of duties and that adequately restrict user and privileged access to financial applications, programs and data to appropriate Company personnel; (iii) computer operations controls to ensure data backups are authorized and restorations monitored; and (iv) testing and approval controls for program development to ensure that new software development is aligned with business and IT requirements. |
Notes: | Represents full-year data for calendar year 2020 except for cumulative number. |
• | differentiated business value that includes behavioral analytics, which find threats that other tools cannot; |
• | real-time threat-sharing across communities; and |
• | value to the Collective Defense ecosystem through integrations. |
(1) | Summation of revenues generated from solutions for Security Information and Event Management (SIEM) Software, IDPS Equipment, Enterprise Data Loss Prevention, Threat Intelligence Software, Network Detection and Response, and Network Access Control. |
• | First-generation NDR vendors such as DarkTrace or Vectra Networks, who offer point products based on Bayesian analysis, outlier analysis, and heuristic detection-based detection; |
• | Network security vendors, such as Cisco and Palo Alto Networks, Inc., who are supplementing their core network security additional behavioral-based detection with behavioral-based detection, threat intelligence and security operations solutions; and |
• | Legacy network infrastructure and performance monitoring companies such as ExtraHop and Arista Networks, who are adding security use cases to their infrastructure products. |
• | Detect advanced network threats and to prevent security breaches; |
• | Anonymously correlate and share threats in real-time across a community of peer enterprises; |
• | Share human-intelligence across a Collective Defense community on how peer enterprises have rated and triaged similar detections; and |
• | Integrate with other participants in the security ecosystem. |
• | Time to value, price, and total cost of ownership; |
• | Brand awareness, reputation, and trust in our services; |
• | Strength of sales, marketing, and channel partner relationships; and |
• | Customer success, cyber hunt, and cyber advisory services. |
Name |
Age |
Position | ||||
Executive Officers |
||||||
GEN Keith B. Alexander (Ret.) |
70 | Co-Chief Executive Officer, President and Chairman | ||||
William E. Welch |
54 | Co-Chief Executive Officer and Director | ||||
James C. Gerber |
61 | Chief Financial Officer | ||||
Donald Closser |
53 | Chief Product Officer | ||||
Non-Employee Directors |
||||||
Donald R. Dixon (1) |
74 | Director | ||||
Mary E. Gallagher (1) |
56 | Director | ||||
Gen. John M. Keane (Ret.) (3) |
78 | Director | ||||
Robert V. “Rob” LaPenta Jr. (2) |
52 | Director | ||||
Vadm. John M. McConnell (Ret.) (2) . |
78 | Director | ||||
André Pienaar (3) |
51 | Director | ||||
Hon. Michael J. Rogers (1) |
58 | Director | ||||
Theodore E. Schlein (2) |
57 | Director | ||||
Vadm. Jan E. Tighe (Ret.) (3) |
59 | Director |
(1) | Member the Audit Committee. |
(2) | Member of the Compensation Committee. |
(3) | Member of the Nominating and Corporate Governance Committee. |
• | the Class I directors are Donald R. Dixon, Theodore E. Schlein and André Pienaar, and their terms will expire at the annual meeting of stockholders to be held in 2022; |
• | the Class II directors are Vadm. John M. McConnell (Ret.), Hon. Michael J. Rogers, Gen. John M. Keane (Ret.) and Robert “Rob” LaPenta Jr., and their terms will expire at the annual meeting of stockholders to be held in 2023; and |
• | the Class III directors are Mary E. Gallagher, William E. Welch, Vadm. Jan E. Tighe (Ret.) and GEN Keith B. Alexander (Ret.), and their terms will expire at the annual meeting of stockholders to be held in 2024. |
• | helping the Board oversee corporate accounting and financial reporting processes; |
• | managing the selection, engagement, qualifications, independence and performance of a qualified firm to serve as the independent registered public accounting firm to audit the financial statements; |
• | discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent accountants, the interim and year-end operating results; |
• | developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters; |
• | reviewing related person transactions; |
• | obtaining and reviewing a report by the independent registered public accounting firm at least annually that describes internal quality control procedures, any material issues with such procedures and any steps taken to deal with such issues when required by applicable law; and |
• | approving or, as permitted, pre-approving, audit and permissible non-audit services to be performed by the independent registered public accounting firm. |
• | reviewing and approving the compensation of the co-chief executive officers, other executive officers and senior management; |
• | administering the equity incentive plans and other benefit programs; |
• | reviewing, adopting, amending and terminating incentive compensation and equity plans, severance agreements, profit sharing plans, bonus plans, change-of-control |
• | reviewing and establishing general policies relating to compensation and benefits of the employees, including the overall compensation philosophy. |
• | identifying and evaluating candidates, including the nomination of incumbent directors for reelection and nominees recommended by stockholders, to serve on the Board; |
• | considering and making recommendations to the board of directors regarding the composition and chairmanship of the committees of the Board; |
• | developing and making recommendations to the board of directors regarding corporate governance guidelines and matters, including in relation to corporate social responsibility; and |
• | overseeing periodic evaluations of the performance of the Board, including its individual directors and committees. |
• | for any transaction from which the director derives an improper personal benefit; |
• | for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; |
• | for any unlawful payment of dividends or redemption of shares; or |
• | for any breach of a director’s duty of loyalty to the corporation or its stockholders. |
• | GEN Keith B. Alexander (Ret.), our Chairman, President and Co-Chief Executive Officer; |
• | William Welch, our Co-Chief Executive Officer; |
• | James C. Gerber, our Chief Financial Officer; |
• | Donald Closser, our Chief Product Officer; and |
• | Sean Foster, our former Chief Revenue Officer. |
Name and Principal Position |
Fiscal Year |
Salary ($) |
Bonus ($) |
Stock Awards ($) (1) |
Non-Equity Incentive Plan Compensation ($) (2) |
All Other Compensation ($) (3) |
Total ($) |
|||||||||||||||||||||
Gen Keith B. Alexander (Ret.) |
2022 | 360,000 | — | — | — | 15,544 | 375,544 | |||||||||||||||||||||
Chairman, President and Co-Chief Executive Officer |
2021 | 339,000 | — | — | 44,350 | 10,680 | 394,030 | |||||||||||||||||||||
William E. Welch |
2022 | 360,000 | — | — | — | 11,192 | 371,192 | |||||||||||||||||||||
Co-Chief Executive Officer |
2021 | 339,000 | — | — | 44,350 | 11,400 | 394,750 | |||||||||||||||||||||
James C. Gerber |
2022 | 340,000 | 125,000 | (5) |
695,673 | — | 12,183 | 1,172,856 | ||||||||||||||||||||
Chief Financial Officer(4) |
||||||||||||||||||||||||||||
Donald Closser |
2022 | 330,000 | — | 627,671 | — | 11,152 | 968,823 | |||||||||||||||||||||
Chief Product Officer(4) |
||||||||||||||||||||||||||||
Sean Foster |
2022 | 275,000 | (6) |
— | 627,671 | 113,204 | 1,462,420 | 2,478,295 | ||||||||||||||||||||
Former Chief Revenue Officer |
2021 | 383,336 | (7) |
— | — | 88,029 | 11,948 | 483,313 |
(1) | The amounts in this column reflect the aggregate grant date fair value of restricted stock units, or RSUs, granted in the applicable year, computed in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification Topic 718 for stock-based compensation transactions. |
(2) | For officers other than Mr. Foster, the amounts in this column reflect cash incentive bonuses earned under our bonus plan during the respective year and paid during the first quarter of the following year. For Mr. Foster only, amount represent sales commissions. |
(3) | Amounts in this column consist primarily of 401(k) plan matching contributions. For Mr. Foster, amounts for fiscal 2022 also include (a) cash severance payments of $150,000, (b) post-termination benefit payments in the amount of $14,303, and (c) $1,288,680, representing the value of acceleration of vesting of restricted stock units to the date of termination. |
(4) | Mr. Gerber and Mr. Closser were not named executive officers for fiscal 2021, and as a result their compensation for that year has been omitted pursuant to applicable SEC rules and regulations. |
(5) | Amount represents a discretionary bonus paid upon the closing of the Business Combination. |
(6) | Mr. Foster’s employment with our company ceased on December 31, 2021, and amounts in this table for fiscal 2022 represent amounts paid or earned for service through that date. |
(7) | Consists of $300,000 in base salary and $83,336 in sales commissions, including non-recoverable draws against such commissions. |
Option Awards |
Stock Awards |
|||||||||||||||||||||||||||||||
Name |
Number of Securities Underlying Unexercised Options Exercisable (#) |
Number of Securities Underlying Unexercised Options Unexercisable (#) |
Option Exercise Price ($) |
Option Expiration Date (1) |
Number of Shares or Units of Stock That Have Not Vested (#) |
Market Value of Shares or Units of Stock That Have Not Vested ($) (2) |
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#) |
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested ($) (2) |
||||||||||||||||||||||||
William E. Welch |
4,438,674 | (3) |
15,135,878 | |||||||||||||||||||||||||||||
244,126 | (4) |
832,470 | ||||||||||||||||||||||||||||||
244,126 | (5) |
832,470 | 983,905 | (6) |
3,355,116 | |||||||||||||||||||||||||||
James C. Gerber |
81,412 | — | 0.58 | 4/23/2027 | ||||||||||||||||||||||||||||
94,842 | (3) |
323,411 | ||||||||||||||||||||||||||||||
Donald Closser |
659,426 | (3) |
2,248,643 | |||||||||||||||||||||||||||||
Sean Foster |
1,043,684 | (3) |
3,558,962 |
(1) | The expiration date of each stock option is ten years from the date of grant. |
(2) | The market value amount is calculated based on the closing price of our common stock of $3.41 on January 31, 2022. |
(3) | These shares represent time-based RSUs outstanding at January 31, 2022 which vested 25% on the first anniversary of their grant date, with the remaining 75% vesting thereafter in 36 monthly installments, subject to the officer’s continuous service as of each vesting date. Certain of the amounts vested at January 31, 2022 remained subject to a liquidity event condition that was satisfied subsequent to January 31, 2022, at which time the vested portion of the RSUs were settled and shares were issued to the officer, net of shares sold to satisfy tax withholding obligations. |
(4) | Of the shares underlying this restricted stock unit award, 25% will vest on July 31, 2022 and the remainder will vest in 36 monthly installments thereafter, such that the award will be fully vested on July 31, 2025, subject to the officer’s continuous service as of each such vesting date. |
(5) | Of the shares underlying this restricted stock unit award, 25% will vest on August 26, 2022 and the remainder will vest in 36 monthly installments thereafter, such that the award will be fully vested on August 26, 2025, subject to the officer’s continuous service as of each such vesting date. |
(6) | These shares represent RSUs granted in February 2019 as performance-based grants. The vesting of these shares will be based on the achievement of specified performance conditions. |
• | arrange for the assumption, continuation or substitution of a stock award by an acquiring or succeeding entity or an affiliate; |
• | provide that an award will become exercisable, realizable or deliverable, or restrictions applicable to the award will lapse, in whole or part, prior to or upon the reorganization event (accelerate the vesting of the award); |
• | upon written notice to a holder of an award, provide that all of the unexercised awards will terminate immediately prior to the consummation of such reorganization event unless exercised (to the extent exercisable) within a specified period following the date of such notice; |
• | In the case of a reorganization event under which the holders of IronNet’s common stock will receive a cash payment for each share surrendered in such reorganization event (the acquisition price), cancel or arrange for the cancellation of the stock award in exchange for a cash payment equal to the number of shares of IronNet’s common stock subject to the vested portion of the award, multiplied by the excess of (1) the acquisition price, over (2) the exercise, measurement or purchase price otherwise payable in connection with the award; or |
• | any combination of the foregoing. |
Name |
CASH ($) FEES EARNED OR PAID IN CASH ($) |
STOCK AWARDS ($) (1) |
TOTAL ($) |
|||||||||
Donald R. Dixon (2) |
16,369 | 196,320 | 212,689 | |||||||||
Mary E. Gallagher (3) |
21,538 | 196,320 | 217,858 | |||||||||
Gen. John M. Keane (Ret.) (4) |
14,431 | 196,320 | 210,751 | |||||||||
Robert V. “Rob” LaPenta Jr. (3) |
15,077 | 196,320 | 211,397 | |||||||||
Vadm. John M. McConnell (Ret.) (4) |
18,092 | 196,320 | 214,412 | |||||||||
André Pienaar (3) |
14,431 | 196,320 | 210,751 | |||||||||
Hon. Michael J. Rogers (4) |
16,369 | 196,320 | 212,689 | |||||||||
Theodore E. Schlein (3) |
15,077 | 196,320 | 211,397 | |||||||||
Vadm. Jan E. Tighe (Ret.) (5) |
16,154 | 196,320 | 212,474 |
(1) | This column reflects the aggregate grant date fair value of restricted stock units granted during the year measured pursuant to Financial Accounting Standard Board Accounting Standards Codification Topic 718, |
the basis for computing stock-based compensation in IronNet’s consolidated financial statements. This calculation assumes that the director will perform the requisite service for the award to vest in full as required by SEC rules. The assumptions used in valuing options are described in Note 6 to IronNet’s consolidated financial statements included in this prospectus. These amounts do not reflect the actual economic value that will be realized by the director upon settlement of the restricted stock units or the sale of the common stock underlying such restricted stock units. |
(2) | The director held an aggregate of 271,672 restricted stock units as of January 31, 2022. |
(3) | The director held an aggregate of 24,000 restricted stock units as of January 31, 2022. |
(4) | The director held an aggregate of 387,252 restricted stock units as of January 31, 2022. |
(5) | The director held an aggregate of 139,580 restricted stock units as of January 31, 2022. |
MEMBER ANNUAL FEE |
CHAIRMAN ADDITIONAL ANNUAL FEE |
|||||||
Board of Directors |
$ | 30,000 | $ | 20,000 | ||||
Audit Committee |
8,000 | 20,000 | ||||||
Compensation Committee |
5,000 | 12,000 | ||||||
Nominating and Corporate Governance Committee |
3,500 | 7,500 |
• | the amounts involved exceeded or will exceed $120,000; and |
• | any of our directors, executive officers or holders of more than 5% of our capital stock, or any member of the immediate family of, or person sharing the household with, the foregoing persons, had or will have a direct or indirect material interest. |
Borrower |
Date of Promissory Note |
Largest Aggregate Amount of Principal Outstanding During the Period |
Amount Outstanding as of Closing of Business Combination |
Annual Rate or Amount of Interest Payable on the Indebtedness |
||||||||||||
James Heath |
12/29/2018 | $ | 1,000,000 | — | 2.8 | % | ||||||||||
James Gerber |
10/24/2019 | $ | 435,836 | — | 1.7 | % |
Stockholder |
Shares of Series B-2 Preferred Stock Purchased |
Total Purchase Price (in millions of dollars) |
||||||
C5 Partners, LLC (2) |
2,791,870 | $ | 25.0 | |||||
Entities affiliated with ForgePoint Capital (3) |
1,383,280 | $ | 12.4 | |||||
KPCB Holdings, Inc., as nominee (4) |
558,370 | $ | 5.0 |
(1) | Each share of Series B-2 convertible preferred stock converted into ten shares of IronNet common stock immediately following the consummation of the Business Combination. After further application of the Merger Exchange Ratio of 0.814107, the numbers presented herein are expressed on an as-converted to IronNet common stock basis. |
(2) | This entity beneficially owns more than 5% of IronNet’s capital stock. André Pienaar, a member of our board of directors and that of Legacy IronNet, is an affiliate of C5 Capital. |
(3) | Consists of 1,103,900 shares purchased by ForgePoint Cybersecurity Fund I, L.P., 1,284 shares purchased by ForgePoint Cyber Affiliates Fund I, L.P. and 266,540 shares purchased by ForgePoint Cyber Co-Investors I-E, L.P. Donald R. Dixon, a member of our board of directors and that of Legacy IronNet, is an affiliate of ForgePoint Capital, of which the foregoing purchasers are affiliated funds. These entities collectively beneficially own more than 5% of IronNet’s capital stock. |
(4) | KPCB Holdings, Inc., as nominee beneficially owns more than 5% of IronNet’s capital stock. Ted Schlein, a member of our board of directors and that of Legacy IronNet, is an affiliate of KPCB Holdings, Inc. |
Stockholder |
Shares of Series B-1 Preferred Stock Purchased |
Total Purchase Price (in millions of dollars) |
||||||
C5 Partners, LLC (2) |
3,908,620 | $ | 35.0 | |||||
Entities affiliated with ForgePoint Capital (3) |
3,886,280 | $ | 34.8 | |||||
KPCB Holdings, Inc., as nominee (4) |
670,050 | $ | 6.0 |
(1) | Each share of Series B-1 convertible preferred stock converted into ten shares of Legacy IronNet common stock immediately prior to the consummation of the Business Combination. The numbers presented herein are expressed on an as-converted to Legacy IronNet common stock basis. |
(2) | This entity beneficially owns more than 5% of IronNet’s capital stock. André Pienaar, a member of our board of directors and that of Legacy IronNet, is an affiliate of C5 Capital. |
(3) | Consists of 1,159,110 shares purchased by ForgePoint Cybersecurity Fund I, L.P., 748,220 shares purchased by ForgePoint Cyber Co-Investors I-B, L.P., 1,965,475 shares purchased by ForgePoint Cyber Co-Investors I-C, L.P., and 13,475 shares purchased by ForgePoint Cyber Affiliates Fund I, L.P. Donald R. Dixon, a member of our board of directors and that of Legacy IronNet, is an affiliate of ForgePoint Capital, of which the foregoing purchasers are affiliated funds. These entities collectively beneficially own more than 5% of IronNet’s capital stock. |
(4) | KPCB Holdings, Inc., as nominee beneficially owns more than 5% of IronNet’s capital stock. Ted Schlein, a member of our board of directors and that of Legacy IronNet, is an affiliate of KPCB Holdings, Inc. |
Stockholder |
Shares of Series A Preferred Stock Purchased |
Total Purchase Price (in millions of dollars) |
||||||
Entities affiliated with ForgePoint Capital (2) |
2,982,070 | $ | 15.0 | |||||
KPCB Holdings, Inc., as nominee (3) |
2,982,070 | $ | 15.0 |
(1) | Each share of Series A convertible preferred stock converted into ten shares of Legacy IronNet common stock immediately prior to the consummation of the Business Combination. The numbers presented herein are expressed on an as-converted to Legacy IronNet common stock basis. |
(2) | Consists of 1,491,035 shares purchased by ForgePoint Cyber Co-Investors I, L.P., 1,473,900 shares purchased by ForgePoint Cybersecurity Fund I, L.P., and 17,135 shares purchased by ForgePoint Cyber Affiliates Fund I, L.P. Donald R. Dixon, a member of our board of directors and that of Legacy IronNet, is an affiliate of ForgePoint Capital, of which the foregoing purchasers are affiliated funds. These entities collectively beneficially own more than 5% of IronNet’s capital stock. |
(3) | KPCB Holdings, Inc., as nominee beneficially owns more than 5% of IronNet’s capital stock. Ted Schlein, a member of our board of directors and that of IronNet, is an affiliate of KPCB Holdings, Inc. |
• | the risks, costs, and benefits to us; |
• | the impact on a director’s independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated; |
• | the terms of the transaction; |
• | the availability of other sources for comparable services or products; and |
• | the terms available to or from, as the case may be, unrelated third parties. |
• | each person known by us to be the beneficial owner of more than 5% of our common stock; |
• | each of our named executive officers and directors; and |
• | all of our current executive officers and directors as a group. |
Name and Address of Beneficial Owner (1) |
Number of Shares |
Percentage of Common Stock Outstanding |
||||||
5% or Greater Stockholders |
||||||||
Entities affiliated with ForgePoint (2) |
10,100,057 | 11.4 | % | |||||
Entities affiliated with C5 Partners (3) |
6,794,861 | 7.6 | % | |||||
Entities affiliated with Kleiner Perkins Caufield & Byers (4) |
6,002,001 | 6.8 | % | |||||
Named Executive Officers and Directors |
||||||||
GEN Keith B. Alexander (Ret.) (5) . . . . . . . . . . . . . . . . . . . . . . . . . . |
11,053,024 | 12.4 | % | |||||
William E. Welch (6) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
3,459,249 | 3.7 | % | |||||
James C. Gerber (7) |
947,752 | 1.1 | % | |||||
Donald Closser (8) |
397,538 | * | ||||||
Sean Foster (9) |
1,011,515 | 1.1 | % | |||||
Donald R. Dixon (10) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
10,447,729 | 11.8 | % | |||||
Mary E. Gallagher . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
15,000 | * | ||||||
Vadm. John M. McConnell (Ret.) (11) . . . . . . . . . . . . . . . . . . . . . . . . |
363,251 | * | ||||||
Gen. John M. Keane (Ret.) (12) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
388,251 | * | ||||||
André Pienaar (3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
6,794,861 | 7.6 | % | |||||
Hon. Michael J. Rogers (13) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
376,548 | * | ||||||
Theodore E. Schlein (14) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
6,102,001 | 6.9 | % | |||||
Vadm. Jan E. Tighe (Ret.) (15) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
115,579 | * | ||||||
Robert V. “Rob” LaPenta Jr. . . . . . . . . . . . . . . . . . . . . . . . . . . . . |
25,000 | * | ||||||
All current directors and executive officers as a group (13 individuals) (16) |
40,485,783 | 43.4 | % |
(1) | Unless otherwise noted, the business address of each of the following entities or individuals is c/o IronNet, Inc., 7900 Tysons One Place, Suite 400, McLean, Virginia, 22102. |
(2) | Includes (i) 52,869 shares of common stock held by ForgePoint Cyber Affiliates Fund I, L.P., (ii) 2,278,138 shares of common stock held by ForgePoint Cyber Co-Investors I, L.P., (iii) 758,760 shares of common stock held by ForgePoint Cyber Co-Investors I-B, L.P., (iv) 1,993,158 shares of common stock held by ForgePoint Cyber Co-Investors I-C, L.P., (v) 270,293 shares of common stock held by ForgePoint Cyber Co-Investors I-E, L.P., and (vi) 4,746,839 shares of common stock held by ForgePoint Cybersecurity Fund I, L.P. ((i) to (vi), inclusive, the “ForgePoint Funds”). Donald R. Dixon and Alberto Yepez are the managing |
members of ForgePoint Cybersecurity GP-1, LLC, which is the general partner of each of the ForgePoint Funds and exercise shared voting, investment and dispositive rights with respect to the shares of stock held by each of the ForgePoint Funds. The address for all entities and individuals affiliated with the ForgePoint Funds is 400 S El Camino Road, Suite 300, San Mateo, CA 94402. |
(3) | André Pienaar (a director of the company), William Kilmer and James Coats are the directors of C5 Investors General Partner Limited, which acts on behalf of C5 Investors LP, the sole manager of C5 Partners LLC. C5 Capital Limited is the investment manager of C5 Investors LP and exercises voting, investment and dispositive rights with respect to the shares of stock held by C5 Investors LLC. André Pienaar is the chief executive officer and a director of C5 Capital Limited together with William Kilmer and Linda Zecher. The address of the entities and individuals affiliated with C5 Capital Limited is 7 Vigo Street, London, W1S 3HF, UK . |
(4) | Includes (i) 5,853,150 shares of common stock held by KPCB Digital Growth Fund II, LLC (“KPCB DGF II”), and (ii) 148,851 shares of common stock held by KPCB Digital Growth Founders Fund, LLC (“DGF II Founders,” together, the “Kleiner Funds”). The Kleiner Funds’ shares are held for convenience in the name of KPCB Holdings, Inc., as nominee, for the accounts of such individuals and entities. The managing member of the Kleiner Funds is KPCB DGF II Associates, LLC (“DGF II Associates”). Theodore E. Schlein (a director of the company), together with L. John Doerr and Mary Meeker, the managing members of DGF II Associates, exercise shared voting and dispositive control over the shares held by the Kleiner Funds. The principal business address for all entities and individuals affiliated with Kleiner Perkins Caufield & Byers is c/o Kleiner Perkins Caufield & Byers, LLC, 2750 Sand Hill Road, Menlo Park, CA 94025. |
(5) | Excludes shares of common stock held by trusts established by GEN Alexander, as (a) each such trust is an irrevocable trust, (b) neither GEN Alexander nor his spouse serve as trustee of any such trust, and (c) GEN Alexander does not otherwise exercise voting, investment or dispositive control over the shares of common stock held by the trusts. |
(6) | Consists of (i) 37,772 shares of common stock and (ii) 3,421,477 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(7) | Consists of (i) 870,337 shares of common stock and (ii) 77,415 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(8) | Consists of (i) 3,763 shares of common stock and (ii) 393,775 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(9) | Consists of (i) 8,535 shares of common stock and (ii) 1,002,980 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(10) | Includes (i) the 10,100,057 shares held by the ForgePoint Funds as described in footnote (2) above, (ii) 100,000 shares of common stock held by The Dixon Revocable Trust, of which Mr. Dixon and his spouse are co-trustees, and (iii) 247,672 shares of common stock held directly by Mr. Dixon. |
(11) | Consists of (i) 249,277 shares of common stock and (ii) 113,974 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(12) | Consists of (i) 274,277 shares of common stock and (ii) 113,974 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(13) | Consists of (i) 262,574 shares of common stock and (ii) 113,974 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(14) | Consists of the shares described in footnote (4) above and 100,000 shares of common stock held by the Schlein Family Trust, of which Mr. Schlein is the trustee. |
(15) | Consists of (i) 1,605 shares of common stock and (ii) 113,974 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
(16) | Consists of (i) 36,137,220 shares of common stock and (ii) 4,348,563 shares of common stock issuable upon the settlement of restricted stock units that will vest within 60 days of January 31, 2022. |
Number of Shares of Common Stock Owned Prior to Offering |
Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus |
Number of Shares of Common Stock Owned After Offering |
||||||||||||||||||
Name of Selling Stockholder |
Number (1) |
Percent (2) |
Number (3) |
Percent (2) |
||||||||||||||||
Tumim Stone Capital LLC (4) |
— | — | 48,503,325 | 48,503,325 | 34 | % |
(1) | In accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number of shares beneficially owned prior to the offering all of the shares that Tumim Stone Capital LLC may be required to purchase under the Purchase Agreement, because the issuance of such shares is solely at our discretion and is subject to conditions contained in the Purchase Agreement, the satisfaction of which are entirely outside of Tumim Stone Capital LLC’s control, including the registration statement that includes this prospectus becoming and remaining effective. Furthermore, the VWAP Purchases of common stock are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any shares of our common stock to Tumim Stone Capital LLC to the extent such shares, when aggregated with all other shares of our common stock then beneficially owned by Tumim Stone Capital LLC, would cause Tumim Stone Capital LLC’s beneficial ownership of our common stock to exceed the 9.99% Beneficial Ownership Cap. The Purchase Agreement also prohibits us from issuing or selling shares of our common stock under the Purchase Agreement in excess of the 19.99% Exchange Cap, unless we obtain stockholder approval to do so, or unless sales of common stock are made at a price equal to or greater than $3.6080 per share, such that the Exchange Cap limitation would not apply under applicable New York Stock Exchange rules. Neither the Beneficial Ownership Cap nor the Exchange |
Cap (to the extent applicable under New York Stock Exchange rules) may be amended or waived under the Purchase Agreement. |
(2) | Applicable percentage ownership is based on 95,347,493 shares of our common stock outstanding as of March 7, 2022. |
(3) | Assumes the sale of all shares being offered pursuant to this prospectus. |
(4) | The business address of Tumim Stone Capital LLC is 140 Broadway, 38th Floor, New York, NY 10005. Tumim Stone Capital LLC’s principal business is that of a private investor. Maier Joshua Tarlow is the manager of 3i Management, LLC, the general partner of 3i, LP, which is the sole member of Tumim Stone Capital LLC, and has sole voting control and investment discretion over securities beneficially owned directly by Tumim Stone Capital LLC and indirectly by 3i Management, LLC and 3i, LP. 3i Management, LLC is also the manager of Tumim Stone Capital LLC. We have been advised that none of Mr. Tarlow, 3i Management, LLC, 3i, LP or Tumim Stone Capital LLC is a member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, or an affiliate or associated person of a FINRA member or independent broker-dealer. The foregoing should not be construed in and of itself as an admission by Mr. Tarlow as to beneficial ownership of the securities beneficially owned directly by Tumim Stone Capital LLC and indirectly by 3i Management, LLC and 3i, LP. |
• | an individual who is a citizen or resident of the United States; |
• | a corporation, or an entity treated as a corporation for U.S. federal income tax purposes, created or organized in the United States or under the laws of the United States or of any state thereof or the District of Columbia; |
• | an estate, the income of which is subject to U.S. federal income tax regardless of its source; or |
• | a trust if (a) a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons have the authority to control all of the trust’s substantial decisions or (b) the trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person. |
• | the gain is effectively connected with the conduct of a trade or business by the non-U.S. Holder within the United States (and, if an applicable tax treaty so requires, is attributable to a U.S. permanent establishment or fixed base maintained by the non-U.S. Holder); |
• | the non-U.S. Holder is an individual who is present in the United States for 183 days or more in the taxable year of disposition and certain other conditions are met; or |
• | we are or have been a “United States real property holding corporation” for U.S. federal income tax purposes at any time during the shorter of the five-year period ending on the date of disposition or the period that the non-U.S. Holder held our common stock or Warrants and, in the case where shares of our common stock are regularly traded on an established securities market, (i) the non-U.S. Holder has owned, actually or constructively, more than 5% of our common stock at any time within the relevant period or (ii) provided that our Warrants are regularly traded on an established securities market, the non-U.S. Holder has owned, actually or constructively, more than 5% of our Warrants at any time within the within the relevant period. It is unclear how a non-U.S. Holder’s ownership of Warrants will affect the determination of whether the non-U.S. Holder owns more than 5% of our common stock. In addition, special rules may apply in the case of a disposition of warrants if our common stock is considered to be regularly traded, but our Warrants are not considered to be publicly traded. There can be no assurance that our common stock or Warrants will or will not be treated as regularly traded on an established securities market for this purpose. |
• | at any time after the warrants become exercisable; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; |
• | if, and only if, the reported last sale price of the shares of common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period commencing at any time after the warrants become exercisable and ending on the third trading day prior to the notice of redemption to warrant holders; and |
• | if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants. |
• | before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder; |
• | upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, those shares owned (1) by persons who are directors and also officers and (2) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or |
• | on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3 % of the outstanding voting stock that is not owned by the interested stockholder. |
• | any merger or consolidation involving the corporation and the interested stockholder; |
• | any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder; |
• | subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder; |
• | any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or |
• | the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation. |
• | permit our board of directors to issue up to 100,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change of control; |
• | provide that the authorized number of directors may be changed only by resolution of our board of directors; |
• | provide that, subject to the rights of any series of preferred stock to elect directors, directors may only be removed in the manner specified in Section 141(k) of the DGCL; |
• | provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum, or by the sole remaining director; |
• | require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent or electronic transmission; |
• | provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder’s notice; |
• | provide that special meetings of our stockholders may be called by (i) the chairperson of the board of directors, (ii) the chief executive officer or (iii) a majority vote of the board of directors; and |
• | not provide for cumulative voting rights, therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose. |
• | 1% of the total number of shares of our common stock then outstanding; or |
• | the average weekly reported trading volume of our common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | issuer of the securities that was formerly a shell company ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10-type information with the SEC reflecting its status as an entity that is not a shell company. |
• | ordinary brokers’ transactions; |
• | transactions involving cross or block trades; |
• | through brokers, dealers, or underwriters who may act solely as agents; |
• | “at the market” into an existing market for the common stock; |
• | in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents; |
• | in privately negotiated transactions; or |
• | any combination of the foregoing. |
Page |
||||
Unaudited Condensed Consolidated Financial Statements as of and for the three and nine months ended October 31, 2021 and 2020 |
||||
F-1 |
||||
F-2 |
||||
F-3 |
||||
F-4 |
||||
F-8 |
||||
F-9 |
||||
Audited Consolidated Financial Statements as of and for the years ended January 31, 2021 and 2020 |
||||
F-24 |
||||
F-25 |
||||
F-26 |
||||
F-27 |
||||
F-28 |
||||
F-29 |
||||
F-30 |
October 31, 2021 |
January 31, 2021 |
|||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | 73,891 | $ | 31,543 | ||||
Accounts receivable |
2,246 | 1,643 | ||||||
Unbilled receivable |
3,885 | 1,425 | ||||||
Related party receivables and loan receivables |
3,521 | 3,599 | ||||||
Account and loan receivables |
9,652 | 6,667 | ||||||
Inventory |
2,672 | 2,180 | ||||||
Deferred costs |
2,416 | 2,068 | ||||||
Prepaid warranty |
814 | 1,037 | ||||||
Prepaid expenses and other current assets |
4,254 | 2,172 | ||||||
Total current assets |
$ | 93,699 | $ | 45,667 | ||||
Deferred costs |
1,320 | 2,056 | ||||||
Property and equipment, net |
5,596 | 2,792 | ||||||
Prepaid warranty |
897 | 878 | ||||||
Deposits and other assets |
490 | 298 | ||||||
Total assets |
$ | 102,002 | $ | 51,691 | ||||
Liabilities and stockholders’ equity |
||||||||
Current liabilities |
||||||||
Accounts payable |
$ | 4,380 | $ | 1,922 | ||||
Accrued expenses |
6,196 | 2,591 | ||||||
Deferred revenue |
12,929 | 12,481 | ||||||
Deferred rent |
154 | 134 | ||||||
Short-term PPP loan |
— | 3,487 | ||||||
Income tax payable |
135 | 88 | ||||||
Other current liabilities |
689 | 689 | ||||||
Total current liabilities |
24,483 | 21,392 | ||||||
Deferred rent |
808 | 928 | ||||||
Deferred revenue |
17,181 | 21,563 | ||||||
Warrants |
43 | — | ||||||
Long-term PPP loan |
— | 2,093 | ||||||
Other long-term liabilities payable |
689 | 689 | ||||||
Total liabilities |
$ | 43,204 | $ | 46,665 | ||||
Commitments and contingencies (Note 7) |
||||||||
Stockholders’ equity |
||||||||
Preferred stock, $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding |
— | — | ||||||
Class A common stock; $0.0001 par value; 500,000,000 shares authorized; 88,718,630 and 65,353,098 shares issued and outstanding at October 31, 2021 and January 31, 2021, respectively |
9 | 7 | ||||||
Additional paid-in capital |
459,349 | 180,853 | ||||||
Accumulated other comprehensive (loss) income |
268 | 40 | ||||||
Accumulated deficit |
(400,828 | ) | (175,039 | ) | ||||
Subscription notes receivable |
— | (835 | ) | |||||
Total stockholders’ equity |
58,798 | 5,026 | ||||||
Total liabilities and stockholders’ equity |
$ | 102,002 | $ | 51,691 | ||||
Three Months Ended October 31, |
Nine Months Ended October 31, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Product, subscription and support revenue |
$ | 6,132 | $ | 5,958 | $ | 18,038 | $ | 18,047 | ||||||||
Professional services revenue |
781 | 1,055 | 1,327 | 3,779 | ||||||||||||
Total revenue |
6,913 | 7,013 | 19,365 | 21,826 | ||||||||||||
Cost of product, subscription and support revenue |
2,082 | 1,252 | 5,505 | 3,534 | ||||||||||||
Cost of professional services revenue |
286 | 817 | 617 | 1,596 | ||||||||||||
Total cost of revenue |
2,368 | 2,069 | 6,122 | 5,130 | ||||||||||||
Gross profit |
4,545 | 4,944 | 13,243 | 16,696 | ||||||||||||
Operating expenses |
||||||||||||||||
Research and development |
28,144 | 5,687 | 42,606 | 19,965 | ||||||||||||
Sales and marketing |
57,196 | 7,155 | 72,046 | 23,265 | ||||||||||||
General and administrative |
100,267 | 4,715 | 111,952 | 16,690 | ||||||||||||
Total operating expenses |
185,607 | 17,557 | 226,604 | 59,920 | ||||||||||||
Operating loss |
(181,062 | ) | (12,613 | ) | (213,361 | ) | (43,224 | ) | ||||||||
Other (expense) income, net |
(724 | ) | 178 | (1,070 | ) | 125 | ||||||||||
Change in fair value of warrants liabilities |
(11,302 | ) | — | (11,302 | ) | — | ||||||||||
Loss before income taxes |
(193,088 | ) | (12,435 | ) | (225,733 | ) | (43,099 | ) | ||||||||
Benefit (provision) for income taxes |
(34 | ) | (19 | ) | (56 | ) | (58 | ) | ||||||||
Net loss |
$ | (193,122 | ) | $ | (12,454 | ) | $ | (225,789 | ) | $ | (43,157 | ) | ||||
Basic and diluted net loss per common share |
(2.22 | ) | (0.19 | ) | (3.05 | ) | (0.67 | ) | ||||||||
Weighted average shares outstanding, basic and diluted |
87,178,432 | 65,067,942 | 74,001,217 | 64,064,424 |
Three Months Ended October 31, |
Nine Months Ended October 31, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Net loss |
$ | (193,122 | ) | $ | (12,454 | ) | $ | (225,789 | ) | $ | (43,157 | ) | ||||
Change in net unrealized gains (losses) on available for sale investments, net of tax |
— | (397 | ) | — | (398 | ) | ||||||||||
Foreign currency translations adjustment, net of tax |
303 | (54 | ) | 228 | (4 | ) | ||||||||||
Comprehensive loss |
$ | (192,819 | ) | $ | (12,905 | ) | $ | (225,561 | ) | $ | (43,559 | ) | ||||
Series A |
Series B |
Class A |
Class B |
Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Deficit |
Subscription Notes Receivables |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock |
Preferred Stock |
Common Stock |
Common Stock |
|||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||
Balance at January 31, 2021 |
— | $ | — | — | $ | — | 66,934 | $ | 7 | — | $ | — | $ | 180,853 | $ | (175,039 | ) | $ | 40 | $ | (835 | ) | $ | 5,026 | ||||||||||||||||||||||||||||
Issuance of common stock |
— | — | — | — | 598 | — | — | — | 305 | — | — | — | 305 | |||||||||||||||||||||||||||||||||||||||
Merger recapitalization (Note 2) |
— | — | — | — | 4,555 | 1 | — | — | (12,027 | ) | — | — | — | (12,026 | ) | |||||||||||||||||||||||||||||||||||||
PIPE Shares |
— | — | — | — | 12,500 | 1 | — | — | 109,857 | — | — | — | 109,858 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock related to Public Warrants |
— | — | — | — | 29 | — | — | — | 330 | — | — | — | 330 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock related to Private Warrants |
— | — | — | — | 3,188 | — | — | — | 21,492 | — | — | — | 21,492 | |||||||||||||||||||||||||||||||||||||||
Issuance of earnout |
— | — | — | — | 1,078 | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Interest earned on subscription notes receivable |
— | — | — | — | — | — | — | — | 8 | — | — | (8 | ) | — | ||||||||||||||||||||||||||||||||||||||
Settlement of related party loan receivable for common shares |
— | — | — | — | (108 | ) | — | — | — | (1,075 | ) | — | — | — | (1,075 | ) | ||||||||||||||||||||||||||||||||||||
Payment of note receivable and settlement of note receivables for common shares |
— | — | — | — | (55 | ) | — | — | — | (550 | ) | — | — | 843 | 293 | |||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | 160,156 | — | — | — | 160,156 | |||||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | (225,789 | ) | — | — | (225,789 | ) | |||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 |
— | — | — | — | — | — | — | — | — | — | 228 | — | 228 | |||||||||||||||||||||||||||||||||||||||
Balance at October 31, 2021 |
— | $ | — | — | $ | — | 88,719 | $ | 9 | — | $ | — | $ | 459,349 | $ | (400,828 | ) | $ | 268 | $ | — | $ | 58,798 | |||||||||||||||||||||||||||||
Balance at January 31, 2020, as previously reported |
794 | $ | 32,500 | 1,217 | $ | 88,711 | 36,138 | $ | 4 | 17,607 | $ | 2 | $ | 2,041 | $ | (119,666 | ) | $ | 394 | $ | (900 | ) | $ | (118,125 | ) | |||||||||||||||||||||||||||
Retroactive application of recapitalization (1) |
(794 | ) | (32,500 | ) | (1,217 | ) | (88,711 | ) | 23,984 | 2 | (17,607 | ) | (2 | ) | 121,194 | — | — | — | 121,194 |
Series A |
Series B |
Class A |
Class B |
Additional Paid-In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Deficit |
Subscription Notes Receivables |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock |
Preferred Stock |
Common Stock |
Common Stock |
|||||||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||
Adjusted Balance at January 31, 2020 |
— | $ | — | — | $ | — | 60,122 | $ | 6 | — | $ | — | $ | 123,235 | $ | (119,666 | ) | $ | 394 | $ | (900 | ) | $ | 3,069 | ||||||||||||||||||||||||||||
Issuance of common stock |
— | — | — | — | 5,231 | 1 | — | — | 44,079 | — | — | — | 44,080 | |||||||||||||||||||||||||||||||||||||||
Interest earned on subscription notes receivable |
— | — | — | — | — | — | — | — | 12 | — | — | (12 | ) | — | ||||||||||||||||||||||||||||||||||||||
Payments on subscription notes receivable |
— | — | — | — | — | — | — | — | — | — | — | 47 | 47 | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | 27 | — | — | — | 27 | |||||||||||||||||||||||||||||||||||||||
Unrealized loss on investments |
— | — | — | — | — | — | — | — | — | (398 | ) | — | (398 | ) | ||||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | (43,157 | ) | — | — | (43,157 | ) | |||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 |
— | — | — | — | — | — | — | — | — | — | (4 | ) | — | (4 | ) | |||||||||||||||||||||||||||||||||||||
Balance at October 31, 2020 |
— | $ | — | — | $ | — | 65,353 | $ | 7 | — | $ | — | $ | 167,353 | $ | (162,823 | ) | $ | (8 | ) | $ | (865 | ) | $ | 3,664 | |||||||||||||||||||||||||||
(1) | Prior to the Merger, as defined in Note 1, Series A and Series B preferred stock were converted 1:10 to Class A common stock and Class B common stock were converted 1:1 to Class A common stock, at the Exchange Ratio of approximately 0.8141070. The conversion has been retroactively restated as of January 31, 2020. |
Series A Preferred Stock |
Series B Preferred Stock |
Class A Common Stock |
Class B Common Stock |
Additional Paid- In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Deficit |
Subscription Notes Receivables |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||
Balance at July 31, 2021 |
— | $ | — | — | $ | — | 67,502 | $ | 7 | — | $ | — | $ | 181,181 | $ | (207,706 | ) | $ | (35 | ) | $ | (548 | ) | $ | (27,101 | ) | ||||||||||||||||||||||||||
Issuance of common stock |
— | — | — | — | 30 | — | — | — | 10 | — | — | — | 10 | |||||||||||||||||||||||||||||||||||||||
Merger recapitalization (Note 2) |
— | — | — | — | 4,555 | 1 | — | — | (12,027 | ) | — | — | — | (12,026 | ) | |||||||||||||||||||||||||||||||||||||
PIPE Shares |
— | — | — | — | 12,500 | 1 | — | — | 109,857 | — | — | — | 109,858 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock related to Public Warrants |
— | — | — | — | 29 | — | — | — | 330 | — | — | — | 330 | |||||||||||||||||||||||||||||||||||||||
Issuance of common stock related to Private Warrants |
— | — | — | — | 3,188 | — | — | — | 21,492 | — | — | — | 21,492 | |||||||||||||||||||||||||||||||||||||||
Issuance of earnout |
— | — | — | — | 1,078 | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||
Interest earned on subscription notes receivable |
— | — | — | — | — | — | — | — | 2 | — | — | (2 | ) | — | ||||||||||||||||||||||||||||||||||||||
Settlement of related party loan receivable for common shares |
— | — | — | — | (108 | ) | — | (1,075 | ) | — | — | (1,075 | ) | |||||||||||||||||||||||||||||||||||||||
Settlement of note receivables for common shares |
— | — | — | — | (55 | ) | — | — | — | (550 | ) | — | — | 550 | — | |||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | 160,129 | — | — | — | 160,129 | |||||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | (193,122 | ) | — | — | (193,122 | ) | |||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 |
— | — | — | — | — | — | — | — | — | — | 303 | — | 303 | |||||||||||||||||||||||||||||||||||||||
Balance at October 31, 2021 |
— | $ | — | — | $ | — | 88,719 | $ | 9 | — | $ | — | $ | 459,349 | $ | (400,828 | ) | $ | 268 | $ | — | $ | 58,798 | |||||||||||||||||||||||||||||
Series A Preferred Stock |
Series B Preferred Stock |
Class A Common Stock |
Class B Common Stock |
Additional Paid- In Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Deficit |
Subscription Notes Receivables |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||
Balance at July 31, 2020 |
— | $ | — | — | $ | — | 64,818 | $ | 6 | — | $ | — | $ | 164,929 | $ | (150,369 | ) | $ | 443 | $ | (905 | ) | $ | 14,104 | ||||||||||||||||||||||||||||
Issuance of common stock |
— | — | — | — | 535 | 1 | — | — | 2,449 | — | — | — | 2,450 | |||||||||||||||||||||||||||||||||||||||
Interest earned on subscription notes receivable |
— | — | — | — | — | — | — | — | 4 | — | — | (4 | ) | — | ||||||||||||||||||||||||||||||||||||||
Payments on subscription notes receivable |
— | — | — | — | — | — | — | — | — | — | — | 44 | 44 | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | (29 | ) | — | — | — | (29 | ) | |||||||||||||||||||||||||||||||||||||
Unrealized loss on investments |
— | — | — | — | — | — | — | — | — | — | (397 | ) | — | (397 | ) | |||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | (12,454 | ) | — | — | (12,454 | ) | |||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 |
— | — | — | — | — | — | — | — | — | — | (54 | ) | — | (54 | ) | |||||||||||||||||||||||||||||||||||||
Balance at October 31, 2020 |
— | $ | — | — | $ | — | 65,353 | $ | 7 | — | $ | — | $ | 167,353 | $ | (162,823 | ) | $ | (8 | ) | $ | (865 | ) | $ | 3,664 | |||||||||||||||||||||||||||
Nine Months Ended October 31, |
||||||||
2021 |
2020 |
|||||||
Cash flows from operating activities |
||||||||
Net loss |
$ | (225,789 | ) | $ | (43,157 | ) | ||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
||||||||
Depreciation and amortization |
659 | 935 | ||||||
Loss (Gain) on sale of fixed assets |
(1 | ) | 220 | |||||
Bad debt expense |
— | 33 | ||||||
Employee stock based compensation |
160,156 | 27 | ||||||
Non-cash interest expense |
1,061 | 97 | ||||||
Change in fair value of warrants liabilities |
11,302 | — | ||||||
Non-cash interest income on amounts due from stockholder |
(8 | ) | (12 | ) | ||||
Changes in operating assets and liabilities: |
— | |||||||
Accounts receivable |
(2,984 | ) | (962 | ) | ||||
Deferred costs |
388 | (982 | ) | |||||
Inventories |
(492 | ) | (494 | ) | ||||
Prepaid expenses and other current assets |
(3,157 | ) | (71 | ) | ||||
Deposits and other assets |
(194 | ) | 75 | |||||
Prepaid warranty |
205 | 157 | ||||||
Accounts payable |
1,151 | (976 | ) | |||||
Accrued expenses |
2,552 | 1,388 | ||||||
Income tax payable |
47 | 58 | ||||||
Deferred rent |
(100 | ) | (131 | ) | ||||
Deferred revenue |
(3,934 | ) | 2,689 | |||||
Warrants |
43 | — | ||||||
Other long-term liabilities payable |
0 | 1,209 | ||||||
|
|
|
|
|||||
Net cash used in operating activities |
(59,095 | ) | (39,897 | ) | ||||
|
|
|
|
|||||
Cash flows from investing activities |
||||||||
Purchases of property and equipment |
(2,385 | ) | (425 | ) | ||||
Proceeds from the sale of fixed assets |
228 | 81 | ||||||
Sales of investments |
— | 647 | ||||||
Proceeds from the maturity of investments |
— | 754 | ||||||
|
|
|
|
|||||
Net cash (used in) provided by investing activities |
(2,156 | ) | 1,057 | |||||
|
|
|
|
|||||
Cash flows from financing activities |
||||||||
Proceeds from issuance of common stock |
634 | 44,080 | ||||||
Proceeds from borrowing SVB Bridge loan |
15,000 | — | ||||||
Proceeds from borrowing PPP loan |
— | 5,580 | ||||||
Payment of loan—SVB Bridge |
(15,000 | ) | — | |||||
Payment of PPP loan |
(5,580 | ) | — | |||||
Merger recapitalization |
4,214 | — | ||||||
Proceeds from PIPE Shares |
125,000 | — | ||||||
Payment of transaction costs |
(21,179 | ) | — | |||||
Proceeds from stock subscriptions |
292 | 47 | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
103,381 | 49,707 | ||||||
|
|
|
|
|||||
Effect of exchange rate changes on cash and cash equivalents |
218 | (407 | ) | |||||
Net change in cash and cash equivalents |
42,348 | 10,460 | ||||||
Cash and cash equivalents |
||||||||
Beginning of the period |
$ | 31,543 | $ | 10,806 | ||||
|
|
|
|
|||||
End of the period |
73,891 | 21,266 | ||||||
|
|
|
|
|||||
Supplemental disclosures of non-cash investing and financing activities |
||||||||
Interest earned on subscription notes receivable |
$ | 8 | $ | 12 | ||||
Unpaid purchases of property and equipment |
(1,306 | ) | — | |||||
Non-cash settlement of related party loan receivable for common shares |
(1,075 | ) | — | |||||
Unrealized loss on investment |
— | (2 | ) |
1. |
Organization and Summary of Significant Accounting Policies |
Three Months Ended October 31, |
Nine Months Ended October 31, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
United States |
$ | 6,226 | $ | 6,310 | $ | 17,210 | $ | 20,309 | ||||||||
International |
687 | 703 | 2,155 | 1,517 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | 6,913 | $ | 7,013 | $ | 19,365 | $ | 21,826 | ||||||||
|
|
|
|
|
|
|
|
2. |
Reverse Recapitalization |
Recapitalization and associated transactions |
||||
Cash (Trust) |
$ | 173,015 | ||
Redemptions |
(159,763 | ) | ||
Less: fees to underwriters and advisors |
(9,038 | ) | ||
Net cash received from Merger recapitalization |
4,214 | |||
Issuance of PIPE Shares |
125,000 | |||
Less: PIPE fees to underwriters and advisors |
(21,179 | ) | ||
Net cash received from PIPE Shares and Merger recapitalization |
108,035 | |||
Less: debt settlement |
(21,266 | ) | ||
Net proceeds from Merger recapitalization, PIPE Shares and debt settlement |
$ | 86,769 |
Shares by Type |
Number of shares |
|||
IronNet Class A Common Stock outstanding previous to the Merger |
67,501,813 | |||
Issuance of common stock (exercises of ISOs and warrant) |
28,734 | |||
Number of Shares issued at the date of the Business Combination ( Recapitalization) |
||||
LGL Class A Common Stock outstanding previous to the Merger |
17,250,000 | |||
Less: Redemption of LGL Class A previous to the Merger |
(15,928,889 | ) | ||
Total Class A Shares issued to former LGL shareholders |
1,321,111 | |||
LGL Founders Shares |
3,234,375 | |||
PIPE Shares |
12,500,000 | |||
Number of Share issued at the Merger |
17,055,486 | |||
Number of Shares issued (redeemed) following the consummation of the Merger |
||||
Earnout Shares |
1,078,125 | |||
Private Warrants (Exercised) |
3,188,229 | |||
Public Warrants (Exercised) |
28,719 | |||
Payments on subscription notes receivable |
(54,955 | ) | ||
Shares repurchase related to loan pay-off |
(107,521 | ) | ||
Total Shares of Common Stock as of October 31, 2021 |
88,718,630 |
3. |
Revenue |
Balance at February 1, 2021 |
$ | 2,805 | ||
Cost of revenue recognized |
(1,033 | ) | ||
Costs deferred |
473 | |||
Foreign exchange |
(3 | ) | ||
Balance at October 31, 2021 |
$ | 2,242 | ||
Balance at February 1, 2020 |
3,080 | |||
Cost of revenue recognized |
(832 | ) | ||
Costs deferred |
711 | |||
Foreign exchange |
(3 | ) | ||
Balance at October 31, 2020 |
$ | 2,956 | ||
Balance at February 1, 2021 |
$ | 34,044 | ||
Revenue recognized |
(23,687 | ) | ||
Revenue deferred |
19,765 | |||
Foreign exchange |
(12 | ) | ||
Balance at October 31, 2021 |
$ | 30,110 | ||
Balance at February 1, 2020 |
20,312 | |||
Revenue recognized |
(19,507 | ) | ||
Revenue deferred |
22,196 | |||
Foreign exchange |
— | |||
Balance at October 31, 2020 |
$ | 23,001 | ||
Years Ending January 31, |
||||
2022 (3 months) |
$ | 5,243 | ||
2023 |
10,770 | |||
2024 |
8,174 | |||
2025 |
4,371 | |||
2026 |
1,552 | |||
$ | 30,110 | |||
4. |
Equity |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption; and |
• | if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders. |
5. |
Stock Incentive Plan |
Number of Shares |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Term |
Intrinsic Value of outstanding options |
|||||||||||||
(Years) |
||||||||||||||||
Outstanding at February 1, 2021 |
2,181,668 | 0.53 | 5.9 | 5,572,988 | ||||||||||||
Granted |
— | — | — | — | ||||||||||||
Exercised |
(591,157 | ) | 0.52 | 5.2 | 7,287,806 | |||||||||||
Forfeited or expired |
(115,671 | ) | 0.57 | 5.5 | — | |||||||||||
Outstanding at October 31, 2021 |
1,474,840 | 0.53 | 5.1 | 18,173,257 | ||||||||||||
Exercisable at October 31, 2021 |
1,462,370 | 0.52 | 5.1 | 18,024,597 | ||||||||||||
Number of Shares |
Weighted Average Grant Date Fair Value |
|||||||
Non-vested at February 1, 2021 |
9,712,169 | $ | 11.75 | |||||
Granted |
2,181,077 | 12.85 | ||||||
Vested |
(2,430,871 | ) | 12.85 | |||||
Forfeited or expired |
(1,257,920 | ) | 12.85 | |||||
Non-vested at October 31, 2021 |
8,204,455 | $ | 11.55 | |||||
6. |
Fair Value Measurements |
a. | Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets. |
b. | Level 2 – Observable inputs other than quoted prices that are either directly or indirectly observable for the asset or liability. |
c. | Level 3 – Unobservable inputs that are supported by little or no market activity. |
October 31, |
January 31, |
|||||||||||||||||||||||||||||||
2021 |
2021 |
|||||||||||||||||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||||||||
Cash equivalents |
$ | 102 | $ | — | $ | — | $ | 102 | $ | 102 | $ | — | $ | — | $ | 102 | ||||||||||||||||
Private Warrants |
— | 43 | — | 43 | — | — | — | — | ||||||||||||||||||||||||
Total assets |
$ | 102 | $ | 43 | $ | — | $ | 145 | $ | 102 | $ | — | $ | — | $ | 102 | ||||||||||||||||
7. |
Commitments and Contingencies |
Remaining three months of fiscal 2022 |
286 | |||
2023 |
1,025 | |||
2024 |
755 | |||
2025 |
775 | |||
2026 |
775 | |||
Thereafter |
1,455 | |||
|
|
|||
$ | 5,071 | |||
|
|
8. |
Income Taxes |
9. |
Related Party Transactions |
10. |
Net Loss Per Share Attributable to Common Stockholders |
Three Months Ended October 31, |
Nine Months Ended October 31, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Numerator: Net loss |
$ | (193,122 | ) | $ | (12,454 | ) | $ | (225,789 | ) | $ | (43,157 | ) | ||||
Denominator: Basic and Diluted Weighted-average shares in computing net loss per share attributable to common stockholders |
87,178,432 | 65,067,942 | 74,001,217 | 64,064,424 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss attributable to common stockholders—basic and diluted |
$ | (2.22 | ) | $ | (0.19 | ) | $ | (3.05) | $ | (0.67 | ) |
As of October 31, 2021 |
As of October 31, 2020 |
|||||||
Shares of common stock issuable from stock options |
1,474,840 | 2,671,317 | ||||||
Total RSUs unvested pending settlement |
8,204,455 | 16,102,029 | ||||||
Shares of common stock issuable upon conversion from preferred shares |
— | 21,272,479 | ||||||
Private Warrants |
10,200 | — | ||||||
Public Warrants |
8,596,273 | — | ||||||
|
|
|
|
|||||
Potential common shares excluded from diluted net loss per share |
18,285,768 | 40,045,825 |
11. |
COVID-19—CARES Act. provision |
12. |
Retirement Plans |
13. |
Subsequent Events |
As of January 31, |
||||||||
2021 |
2020 |
|||||||
Assets |
||||||||
Current Assets |
||||||||
Cash and Cash Equivalents |
$ | 31,543 | $ | 10,806 | ||||
Accounts Receivable |
1,643 | 1,216 | ||||||
Unbilled Receivable |
1,425 | 386 | ||||||
Related Party Receivables and Loan Receivables |
3,599 | 1,711 | ||||||
|
|
|
|
|||||
Account and Loan Receivables |
6,667 | 3,313 | ||||||
Investments |
— | 1,401 | ||||||
Inventory |
2,180 | 1,964 | ||||||
Deferred Costs |
2,068 | 1,081 | ||||||
Prepaid Warranty |
1,037 | 806 | ||||||
Prepaid Expenses and Other Current Assets |
2,172 | 1,555 | ||||||
|
|
|
|
|||||
Total Current Assets |
45,667 | 20,926 | ||||||
|
|
|
|
|||||
Non-Current Assets |
||||||||
Deferred Costs |
2,056 | 2,063 | ||||||
Property and Equipment, Net |
2,792 | 3,184 | ||||||
Prepaid Warranty |
878 | 1,519 | ||||||
Deposits and Other Assets |
298 | 398 | ||||||
|
|
|
|
|||||
Total Assets |
$ | 51,691 | $ | 28,090 | ||||
|
|
|
|
|||||
Liabilities, Preferred Stock, and Stockholders’ Equity |
||||||||
Current Liabilities |
||||||||
Accounts Payable |
$ | 1,922 | $ | 1,618 | ||||
Accrued Expenses |
2,591 | 1,844 | ||||||
Deferred Revenue |
12,481 | 7,879 | ||||||
Deferred Rent |
134 | 161 | ||||||
Short-Term PPP Loan |
3,487 | — | ||||||
Income Tax Payable |
88 | 10 | ||||||
Other current liabilities |
689 | — | ||||||
|
|
|
|
|||||
Total Current Liabilities |
21,392 | 11,512 | ||||||
|
|
|
|
|||||
Long-Term Liabilities |
||||||||
Deferred Rent |
928 | 1,059 | ||||||
Deferred Revenue |
21,563 | 12,433 | ||||||
Long-Term PPP Loan |
2,093 | — | ||||||
Other Long-Term Liabilities |
689 | 0 | ||||||
|
|
|
|
|||||
Total Long-Term Liabilities |
25,273 | 13,492 | ||||||
|
|
|
|
|||||
Total Liabilities |
46,665 | 25,004 | ||||||
|
|
|
|
|||||
Commitments and Contingencies (Note 13) |
||||||||
Stockholders’ Equity |
||||||||
Preferred stock, $0.001 par value; 100,000,000 shares authorized; none issued or outstanding |
||||||||
Class A common stock; $0.0001 par value; 500,000,000 shares authorized; 66,933,566 and 60,121,819 shares issued and outstanding at January 31, 2021 and January 31, 2020, respectively |
7 | 6 | ||||||
Additional paid-in capital |
180,853 | 123,251 | ||||||
Accumulated other comprehensive income |
40 | 394 | ||||||
Accumulated deficit |
(175,039 | ) | (119,666 | ) | ||||
Subscription notes receivable |
(835 | ) | (900 | ) | ||||
|
|
|
|
|||||
Total Stockholders’ Equity |
5,026 | 3,086 | ||||||
|
|
|
|
|||||
Total Liabilities and Stockholders’ Equity |
$ | 51,691 | $ | 28,090 | ||||
|
|
|
|
Year Ended January 31, |
||||||||
2021 |
2020 |
|||||||
Software, subscription, and support revenue |
$ | 24,701 | $ | 19,798 | ||||
Professional services revenue |
4,526 | 3,364 | ||||||
|
|
|
|
|||||
Total revenue |
29,227 | 23,162 | ||||||
Cost of software, subscription, and support revenue |
5,393 | 5,904 | ||||||
Cost of services revenue |
1,629 | 726 | ||||||
|
|
|
|
|||||
Total cost of revenue |
7,022 | 6,630 | ||||||
|
|
|
|
|||||
Gross profit |
22,205 | 16,532 | ||||||
|
|
|
|
|||||
Operating expenses |
||||||||
Research and development |
25,754 | 26,587 | ||||||
Sales and marketing |
30,381 | 17,919 | ||||||
General and administrative |
21,347 | 20,451 | ||||||
|
|
|
|
|||||
Total operating expenses |
77,482 | 64,957 | ||||||
|
|
|
|
|||||
Operating loss |
(55,277 | ) | (48,425 | ) | ||||
Other (expense) income, net |
(19 | ) | 567 | |||||
|
|
|
|
|||||
Loss before provision for income taxes |
(55,296 | ) | (47,858 | ) | ||||
Provision for income taxes |
(77 | ) | (11 | ) | ||||
|
|
|
|
|||||
Net loss |
$ | (55,373 | ) | $ | (47,869 | ) | ||
|
|
|
|
|||||
Basic and diluted net loss per common share |
$ | (0.86 | ) | $ | (0.81 | ) | ||
Weighted average shares outstanding, basic and diluted |
64,562 | 58,838 |
Year Ended January 31, |
||||||||
2021 |
2020 |
|||||||
Net loss |
$ | (55,373 | ) | $ | (47,869 | ) | ||
Other comprehensive income (loss), net of tax: |
||||||||
Change in net unrealized (losses) gains on available for sale investments, net of tax |
(397 | ) | 175 | |||||
Foreign currency translations adjustment, net of tax |
42 | (3 | ) | |||||
|
|
|
|
|||||
Total comprehensive loss |
$ | (55,728 | ) | $ | (47,697 | ) | ||
|
|
|
|
Series A Preferred Stock |
Series B Preferred Stock |
Class A Common Stock |
Class A Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
Subscription Notes Receivable |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||||||||||||||||||
Balance at January 31, 2019, as previously reported |
794 |
$ |
32,500 |
1,071 |
$ |
78,086 |
35,690 |
$ |
4 |
17,607 |
$ |
2 |
$ |
1,675 |
$ |
(71,797 |
) |
$ |
222 |
$ |
(793 |
) |
$ |
(70,687 |
) | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retroactive application of recapitalization (1) |
(794 |
) |
(32,500 |
) |
(1,071 |
) |
(78,086 |
) |
22,879 |
2 |
(17,607 |
) |
(2 |
) |
110,585 |
— |
— |
— |
110,585 |
|||||||||||||||||||||||||||||||||
Balance at January 31, 2019 |
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
— |
|
|
|
58,569 |
|
|
$ |
6 |
|
|
|
— |
|
|
$ |
— |
|
|
$ |
112,260 |
|
|
$ |
(71,797 |
) |
|
$ |
222 |
|
|
$ |
(793 |
) |
|
$ |
39,898 |
|
Issuance of common stock |
— | — | — | — | 1,554 | — |
— | — | 10,808 | — | — | (95 | ) | 10,713 | ||||||||||||||||||||||||||||||||||||||
Interest earned on subscription notes receivable |
— | — | — | — | — | — | — | — | 12 | — | — | (12 | ) | — | ||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | 171 | — | — | — | 171 | |||||||||||||||||||||||||||||||||||||||
Unrealized gain on investments |
— | — | — | — | — | — | — | — | — | — | 175 | — | 175 | |||||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | (47,869 | ) | — | — | (47,869 | ) | |||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 ) |
(3 | ) | (3 | ) | ||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Balance at January 31, 2020 |
— | — | — | — | 60,122 | 6 |
— | — |
123,251 | (119,666 | ) |
394 | (900 | ) |
3,086 | |||||||||||||||||||||||||||||||||||||
Issuance of common stock |
— | — | — | — | 6,812 | 1 |
— | — | 57,592 | — | — | — | 57,593 | |||||||||||||||||||||||||||||||||||||||
Interest earned on subscription notes receivable |
— | — | — | — | — | — | — | — | 16 | — | — | (16 | ) | — | ||||||||||||||||||||||||||||||||||||||
Payments on subscription notes receivable |
— | — | — | — | — | — | — | — | — | — | — | 81 | 81 | |||||||||||||||||||||||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | — | — | — | (6 | ) | — | — | — | (6 | ) | |||||||||||||||||||||||||||||||||||||
Unrealized gain on investments |
— | — | — | — | — | — | — | — | — | — | (396 | ) | — | (396 | ) | |||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | — | (55,373 | ) | — | — | (55,373 | ) | |||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment, net of tax of $0 ) |
— | — | — | — | — | — | — | — | — | — | 42 | — | 42 | |||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Balance at January 31, 2021 |
— | — | — |
— |
66,934 |
7 | — |
— |
180,853 |
(175,039 | ) |
40 |
(835 | ) |
5,026 | |||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Prior to the Merger, as defined in Note 1, Series A and Series B preferred stock were converted to Class A common stock and Class B common stock were converted 1:1 to Class A common stock, at the Exchange Ratio of approximately 0.8141070. The conversion has been retroactively restated as of January 31, 2019 . |
Year Ended January 31, |
||||||||
2021 |
2020 |
|||||||
Operating Activities |
||||||||
Net loss |
$ | (55,373 | ) | $ | (47,869 | ) | ||
Adjustments to reconcile net loss to net cash: |
||||||||
Provided by (Used in) Operating Activities: |
||||||||
Depreciation and amortization |
1,162 | 1,026 | ||||||
Loss on disposal of property and equipment |
219 | 7 | ||||||
Bad debt expense |
33 | — | ||||||
Employee stock based compensation |
(6 | ) | 171 | |||||
Changes in Operating Assets and Liabilities: |
||||||||
Accounts receivable |
(3,356 | ) | (170 | ) | ||||
Deferred costs |
(1,038 | ) | 611 | |||||
Inventory |
(217 | ) | (1,469 | ) | ||||
Prepaid expenses and other current assets |
(610 | ) | (190 | ) | ||||
Deposits and other assets |
104 | (77 | ) | |||||
Contract assets |
424 | (305 | ) | |||||
Accounts payable |
1,628 | (1,191 | ) | |||||
Accrued expenses |
751 | 754 | ||||||
Income tax payable |
76 | 7 | ||||||
Deferred rent |
(158 | ) | (106 | ) | ||||
Deferred revenue |
13,711 | 38 | ||||||
Net cash used in operating activities |
(42,650 | ) | (48,763 | ) | ||||
Investing Activities |
||||||||
Purchases of property and equipment |
(952 | ) | (1,054 | ) | ||||
Proceeds from the sale of fixed assets |
61 | 22 | ||||||
Purchases of investments |
— | (11,153 | ) | |||||
Sales of investments |
— | 19,386 | ||||||
Proceeds from the maturity of investments |
1,003 | 16,963 | ||||||
Net cash provided by investing activities |
112 | 24,164 | ||||||
Financing Activities |
||||||||
Proceeds from issuance of common stock |
57,593 | 10,713 | ||||||
Proceeds from borrowing of PPP loan |
5,580 | — | ||||||
Proceeds from stock subscription |
81 | — | ||||||
Net cash provided by financing activities |
63,254 | 10,713 | ||||||
Effect of exchange rate changes on cash and cash equivalents |
21 | (2 | ) | |||||
Net change in cash and cash equivalents |
20,737 | (13,888 | ) | |||||
Cash and Cash Equivalents |
||||||||
Beginning of the period |
10,806 | 24,694 | ||||||
End of the period |
$ | 31,543 | $ | 10,806 | ||||
Supplemental disclosures of non-cash investing and financing activities |
||||||||
Issuance of common stock under subscription note receivable arrangements |
$ | — | $ | 95 | ||||
Interest earned on subscription notes receivable |
$ | 16 | $ | 12 |
1. |
Organization and Summary of Significant Accounting Policies |
• | Identification of the contract, or contracts, with a customer |
party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and the parties are committed to perform, and (iii) the Company determines that collection of substantially all consideration to which it will be entitled in exchange for goods or services that will be transferred is probable based on the customer’s intent and ability to pay the promised consideration. |
• | Identification of the performance obligations in the contract |
• | Determination of the transaction price |
• | Allocation of the transaction price to the performance obligations in the contract |
• | Recognition of revenue when, or as, we satisfy performance obligations |
Computer and other equipment | 3-5 years | |
Leasehold improvements | Shorter of life of lease or life of asset | |
Furniture and fixtures | 7 years | |
Software | 3 years |
2. |
Revenue |
Year Ended January 31, |
||||||||
2021 |
2020 |
|||||||
Customer A |
10% | * | ||||||
Customer B |
* | 14% | ||||||
Customer C |
* | 10% | ||||||
Customer D |
* | 10% | ||||||
Customer E |
* | 14% | ||||||
10 | % | 48 | % | |||||
Balance at February 1, 2019 |
$ | 3,754 | ||
Cost of revenue recognized |
(1,541 | ) | ||
Costs deferred |
867 | |||
Balance at January 31, 2020 |
3,080 | |||
Balance at February 1, 2020 |
3,080 | |||
Cost of revenue recognized |
(1,151 | ) | ||
Costs deferred |
876 | |||
Balance at January 31, 2021 |
$ | 2,805 | ||
Balance at February 1, 2019 |
$ | 20,274 | ||
Revenue recognized |
(15,746 | ) | ||
Revenue deferred |
15,785 | |||
Foreign exchange |
(1 | ) | ||
Balance at January 31, 2020 |
$ | 20,312 | ||
Balance at February 1, 2020 |
$ | 20,312 | ||
Revenue recognized |
(25,271 | ) | ||
Revenue deferred |
38,940 | |||
Foreign exchange |
63 | |||
Balance at January 31, 2021 |
$ | 34,044 | ||
Years Ending January 31, |
||||
2022 |
$ | 12,481 | ||
2023 |
9,565 | |||
2024 |
6,862 | |||
2025 |
4,150 | |||
2026 |
986 | |||
Thereafter |
— | |||
$ | 34,044 | |||
3. |
Prepaid Expenses and Other Current Assets |
2021 |
2020 |
|||||||
Prepaid expenses |
$ | 2,046 | $ | 1,507 | ||||
Other assets |
126 | 48 | ||||||
$ | 2,172 | $ | 1,555 | |||||
4. |
Property and Equipment |
2021 |
2020 |
|||||||
Computer and other equipment |
$ | 3,701 | $ | 3,665 | ||||
Leasehold improvements |
1,582 | 1,582 | ||||||
Furniture and fixtures |
386 | 969 | ||||||
Software |
629 | — | ||||||
6,298 | 6,216 | |||||||
Less: Accumulated depreciation and amortization |
(3,506 | ) | (3,032 | ) | ||||
$ | 2,792 | $ | 3,184 | |||||
5. |
Retirement Plan |
6. |
Stock Incentive Plan |
2021 |
2020 |
|||||||
Expected volatility |
55.0 | % | 50.0 | % | ||||
Expected dividend yield |
0.0 | % | 0.0 | % | ||||
Expected option term (in years) |
2.0 | 2.0 | ||||||
Risk-free interest rate |
0.23 | % | 2.27 | % |
Number of Shares |
Weighted Average Exercise Price |
Average Remaining Contractual Term (Years) |
Intrinsic Value of Outstanding Options |
|||||||||||||
Outstanding at February 1, 2019 |
4,211 |
$ |
0.54 |
6.8 |
$ |
4,431 |
||||||||||
Granted |
— |
— |
— |
|||||||||||||
Exercised |
(365 |
) |
$ |
0.50 |
6.4 |
$ |
397 |
|||||||||
Forfeited or expired |
(244 |
) |
$ |
0.64 |
6.9 |
|||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding at January 31, 2020 |
3,602 |
$ |
0.54 |
6.9 |
$ |
4,088 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Exercisable at January 31, 2020 |
2,638 |
$ |
0.50 |
6.7 |
$ |
3,069 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding at February 1, 2020 |
3,602 |
$ |
0.54 |
5.9 |
$ |
4,088 |
||||||||||
Granted |
— |
— |
— |
|||||||||||||
Exercised |
(403 |
) |
$ |
0.52 |
5.2 |
$ |
468 |
|||||||||
Forfeited or expired |
(1,017 |
) |
$ |
0.57 |
6.1 |
|||||||||||
|
|
|
|
|
|
|
|
|||||||||
Outstanding at January 31, 2021 |
2,182 |
$ |
0.53 |
5.9 |
$ |
5,573 |
||||||||||
|
|
|
|
|
|
|
|
|||||||||
Exercisable at January 31, 2021 |
1,995 |
$ |
0.52 |
5.8 |
$ |
5,116 |
||||||||||
|
|
|
|
|
|
|
|
Number of Shares |
Weighted Average Grant Date Fair Value |
|||||||
Non-vested at February 1, 2019 |
1,592 | $ | 1.58 | |||||
Granted |
13,969 | 1.63 | ||||||
Vested |
(909 | ) | 1.63 | |||||
Forfeited or expired |
(255 | ) | 1.62 | |||||
|
|
|
|
|||||
Non-vested at January 31, 2020 |
14,397 | $ | 1.62 | |||||
|
|
|
|
|||||
Non-vested at February 1, 2020 |
14,397 | $ | 1.62 | |||||
Granted |
2,029 | 3.08 | ||||||
Vested |
(5,090 | ) | 1.70 | |||||
Forfeited or expired |
(1,624 | ) | 2.06 | |||||
|
|
|
|
|||||
Non-vested at January 31, 2021 |
9,712 | $ | 1.82 | |||||
|
|
|
|
7. |
Preferred Stock and Stockholders’ Equity |
8. |
Fair Value Measurements |
• | Level 1—Quoted prices (unadjusted) for identical assets or liabilities in active markets; |
• | Level 2—Observable inputs other than quoted prices that are either directly or indirectly observable for the asset or liability; |
• | Level 3—Unobservable inputs that are supported by little or no market activity. |
2021 |
2020 |
|||||||||||||||||||||||||||||||
Level 1 |
Level 2 |
Level 3 |
Total |
Level 1 |
Level 2 |
Level 3 |
Total |
|||||||||||||||||||||||||
Cash equivalents |
$ | 102 | $ | — | $ | — | $ | 102 | $ | 784 | $ | — | $ | — | $ | 784 | ||||||||||||||||
Investments |
— | — | — | — | 1,401 | 1,401 | ||||||||||||||||||||||||||
Total assets |
$ | 102 | $ | — | $ | — | $ | 102 | $ | 784 | $ | 1,401 | $ | — | $ | 2,185 | ||||||||||||||||
9. |
Income Taxes |
2021 |
2020 |
|||||||
Current income taxes |
||||||||
Federal |
$ | — | $ | — | ||||
State |
8 | 8 | ||||||
Foreign |
69 | 3 | ||||||
Deferred income taxes |
— | — | ||||||
Total income tax expense |
$ | 77 | $ | 11 | ||||
2021 |
2020 |
|||||||||||||||
Income tax expense computed at U.S. federal statutory income tax rate |
$ | (11,628 | ) | 21.0 | % | $ | (10,050 | ) | 21.0 | % | ||||||
State income taxes |
(2,257 | ) | 4.1 | % | (1,951 | ) | 4.1 | % | ||||||||
Permanent items |
321 | -0.6 | % | 943 | -2.0 | % | ||||||||||
Valuation Allowance |
13,632 | -24.6 | % | 11,617 | -24.3 | % | ||||||||||
Other |
9 | 0.0 | % | (548 | ) | 1.2 | % | |||||||||
Income tax expense computed at U.S. federal statutory income tax rate |
$ |
77 |
-0.1 |
% |
$ |
11 |
0.0 |
% |
2021 |
2020 |
|||||||
Deferred tax assets |
||||||||
Net operating loss carryforward |
$ | 38,933 | $ | 25,296 | ||||
Accruals and other |
757 | 463 | ||||||
Intangibles |
136 | 135 | ||||||
Depreciation and amortization |
70 | — | ||||||
Deferred Revenue |
2,754 | 3,094 | ||||||
Gross deferred tax assets |
42,650 | 28,988 | ||||||
Valuation allowance |
(41,849 | ) | (28,214 | ) | ||||
Net deferred tax asset |
801 | 774 | ||||||
Deferred tax liabilities |
||||||||
Depreciation and amortization |
— | (23 | ) | |||||
Deferred costs |
(801 | ) | (751 | ) | ||||
Net deferred tax assets (liabilities) |
$ | — | $ | — | ||||
Deferred tax asset valuation allowance |
Beginning Balance |
Charged to Costs & Expenses |
Deductions |
Ending Balance |
||||||||||||
Year Ended |
||||||||||||||||
January 31, 2021 |
$ | 28,214 | 13,635 | — | $ | 41,849 | ||||||||||
January 31, 2020 |
$ | 16,598 | 11,616 | — | $ | 28,214 |
10. |
Geographic Information |
2021 |
2020 |
|||||||
(in thousands) |
||||||||
United States |
$ | 27,147 | $ | 23,123 | ||||
International |
2,080 | 39 | ||||||
Total |
$ | 29,227 | $ | 23,162 | ||||
11. |
Other Accrued Expenses |
12. |
PPP loan |
13. |
Commitments and Contingencies |
Years Ending January 31, |
||||
2022 |
$ | 1,303 | ||
2023 |
1,036 | |||
2024 |
755 | |||
2025 |
775 | |||
2026 |
797 | |||
Thereafter |
658 | |||
$ | 5,324 | |||
14. |
Net Loss Per Share Attributable to Common Shareholders |
Year ended |
||||||||
2021 |
2020 |
|||||||
Numerator: Net loss |
(55,373 | ) | (47,869 | ) | ||||
Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders |
64,562 | 58,838 | ||||||
|
|
|
|
|||||
Net loss attributable to common shareholders - basic and diluted |
$ | (0.86 | ) | $ | (0.81 | ) |
Year ended |
||||||||
2021 |
2020 |
|||||||
Shares of common stock issuable from stock options |
2,182 | 3,602 | ||||||
RSUs subject to future vesting |
15,712 | 15,305 | ||||||
Shares of common stock issuable upon conversion from preferred shares |
22,832 | 16,424 | ||||||
|
|
|
|
|||||
Potential common shares excluded from diluted net loss per share |
40,726 | 35,331 |
15. |
Related Party Transactions |
16. |
Subsequent Events |
Amount |
||||
SEC registration fee |
$ | 19,829 | ||
Accountants’ fees and expenses |
135,000 | |||
Legal fees and expenses |
400,000 | |||
Printing fees |
150,000 | |||
Miscellaneous |
45,171 | |||
|
|
|||
Total expenses |
$ | 750,000 | ||
|
|
(1) | On April 30, 2019, the Sponsor purchased 3,593,750 shares of Class B common stock for an aggregate purchase price of $25,000, or approximately $0.007 per share, in connection with LGL’s organization. In November, 2019, LGL effected a stock dividend of 0.2 shares for each share of LGL Class B common stock outstanding, resulting in the Sponsor holding an aggregate of 4,312,500 shares of LGL Class B common stock, 1,078,125 shares of which were forfeited upon closing of the Business |
Combination. Upon the closing of the Business Combination, each share of LGL Class B common stock outstanding automatically converted into a share of LGL Class A common stock in accordance with LGL’s certificate of incorporation. |
(2) | In November 2019, Sponsor purchased an aggregate of 5,200,000 warrants at a price of $1.00 per warrant generating gross proceeds of $5.2 million. Each warrant is exercisable for one share of our common stock at an exercise price of $11.50 per share. |
(3) | In August 2021, upon the closing of the Business Combination, we issued an aggregate of 12,500,000 shares of Class A Common Stock for an aggregate purchase price of $125.0 million to qualified institutional buyers and accredited investors, at a purchase price of $10.00 per share. |
(4) | Between January 2020 and December 2020, Legacy IronNet sold the current equivalent on a post-merger, as converted basis of 759,517 shares of Common A in shares of its Series B-2 convertible preferred stock at a current equivalent, as converted, purchase price of $89.55 per share for an aggregate amount of $68.0 million, on an as-converted to Legacy IronNet common stock basis. |
(5) | Since April 30, 2019, Legacy IronNet has granted to certain employees, directors and consultants of Legacy IronNet and its subsidiaries RSUs, net of forfeitures and cancellations and restated to their current IronNet share equivalents by applying the Exchange Ratio of 0.814107, representing (i) 8.1 million shares of Legacy IronNet common stock under the 2014 Plan and (ii) 1.3 million shares of Legacy IronNet common stock outside of the 2014 Plan, for an aggregate of 9.4 million shares of Legacy IronNet common stock. Upon the closing of the Business Combination, such RSUs were automatically and without any required action on the part of any holder or beneficiary thereof, assumed by us and converted into RSUs to purchase an aggregate of 7.7 million shares of our common stock. |
Incorporated by Reference | ||||||||||
Exhibit Number |
Description |
Schedule/ Form |
File No. |
Exhibit |
Filing Date | |||||
2.1 | Agreement and Plan of Reorganization and Merger, dated March 15, 2021, by and among the registrant, LGL Systems Merger Sub Inc. and IronNet Cybersecurity, Inc. | S-4/A |
333-256129 |
2.1 | August 6, 2021 | |||||
2.2 | Amendment No. 1 to Agreement and Plan of Reorganization and Merger, dated August 6, 2021, by and among the registrant, LGL Systems Merger Sub Inc. and IronNet Cybersecurity, Inc. | S-4/A |
333-256129 |
2.2 | August 6, 2021 |
Incorporated by Reference | ||||||||||||||
Exhibit Number |
Description |
Schedule/ Form |
File No. |
Exhibit |
Filing Date | |||||||||
10.14+ | Employment Agreement, dated February 7, 2019, by and between the registrant and Sean Foster | S-4/A |
333-256129 |
10.15 | August 6, 2021 | |||||||||
10.15+* | Employment Agreement, dated September 6, 2019, by and between the registrant and James C. Gerber | |||||||||||||
10.16+* | Employment Agreement, dated September 19, 2019, by and between the registrant and Donald Closser | |||||||||||||
10.17 | Common Stock Purchase Agreement, dated February 11, 2022, by and between IronNet, Inc. and Tumim Stone Capital LLC | 8-K | 001-39125 | 10.1 | February 14, 2022 | |||||||||
21.1 | List of Subsidiaries | 8-K |
001-39125 |
21.1 | September 1, 2021 | |||||||||
23.1* | Consent of PricewaterhouseCoopers LLP | |||||||||||||
23.2* | Consent of Cooley LLP (included in Exhibit 5.1) | |||||||||||||
24.1* | Power of Attorney (included on signature page) | |||||||||||||
107* | Filing Fee Table | |||||||||||||
101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because iXBRL tags are embedded within the Inline XBRL document). | |||||||||||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||||||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |||||||||||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||||||||
101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document | |||||||||||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||||||||
104 | Cover Page Interactive Data File, formatted in Inline XBRL (included within the Exhibit 101 attachments) |
* | Filed herewith. |
+ | Indicates a management contract or compensatory plan, contract or arrangement. |
(a) | The undersigned registrant hereby undertakes as follows: |
(1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |
(i) | To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
(ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; |
(iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement. |
(2) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
(3) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. |
(4) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. |
(5) | That, for the purpose of determining any liability under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: |
(i) | Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; |
(ii) | Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; |
(iii) | The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or our securities provided by or on behalf of the undersigned registrant; and |
(iv) | Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser. |
(b) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the undersigned pursuant to the foregoing provisions, or otherwise, the undersigned has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the undersigned of expenses incurred or paid by a director, officer or controlling person of the undersigned in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the undersigned will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |
IRONNET, INC. | ||
By: | /s/ James C. Gerber | |
Name: James C. Gerber | ||
Title: Chief Financial Officer |
Signature | Title | Date | ||
/s/ Keith B. Alexander GEN Keith B. Alexander (Ret.) |
Co-Chief Executive Officer, President and Chairman (Principal Executive Officer) |
March 10, 2022 | ||
/s/ William W. Welch William W. Welch |
Co-Chief Executive Officer and Director |
March 10, 2022 | ||
/s/ James C. Gerber James C. Gerber |
Chief Financial Officer (Principal Financial and Accounting Officer) | March 10, 2022 | ||
/s/ Donald R. Dixon Donald R. Dixon |
Director |
March 10, 2022 | ||
/s/ Mary E. Gallagher Mary E. Gallagher |
Director |
March 10, 2022 | ||
/s/ John M. Keane Gen. John M. Keane (Ret.) |
Director |
March 10, 2022 | ||
/s/ Robert V. LaPenta Jr. Robert V. LaPenta Jr. |
Director |
March 10, 2022 |
/s/ John M. McConnell Vadm. John M. McConnell (Ret.) |
Director |
March 10, 2022 | ||
/s/ André Pienaar André Pienaar |
Director |
March 10, 2022 | ||
/s/ Michael J. Rogers Michael J. Rogers |
Director |
March 10, 2022 | ||
/s/ Theodore E. Schlein Theodore E. Schlein |
Director |
March 10, 2022 | ||
/s/ Jan E. Tighe Vadm. Jan E. Tighe (Ret.) |
Director |
March 10, 2022 |
Exhibit 5.1
Brian F. Leaf
+ 1 703 456-8053
bleaf@cooley.com
March 10, 2022
IronNet, Inc.
7900 Tysons One Place
Suite 400
McLean, VA 22102
Ladies and Gentlemen:
You have requested our opinion, as counsel to IronNet, Inc., a Delaware corporation (the Company), with respect to certain matters in connection with the issuance and sale by the Company of shares of the Companys common stock, par value $0.0001 per share (Common Stock), having aggregate sales proceeds of up to $175,000,000 (the Shares), pursuant to a Registration Statement on Form S-1 (the Registration Statement), filed with the Securities and Exchange Commission (the SEC) under the Securities Act of 1933, as amended (the Securities Act), and the related prospectus contained therein (the Prospectus). The Shares are to be sold by the Company in accordance with a Purchase Agreement, dated February 11, 2022, between the Company and Tumim Stone Capital LLC (the Agreement), as described in the Prospectus.
In connection with this opinion, we have examined and relied upon the Registration Statement and the Prospectus, the Agreement, the Companys Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws, each as currently in effect, and originals or copies certified to our satisfaction of such records, documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to originals of all documents submitted to us as copies, the accuracy, completeness and authenticity of certificates of public officials, and the due authorization, execution and delivery of all documents by all persons other than the Company where authorization, execution and delivery are prerequisites to the effectiveness thereof. As to certain factual matters, we have relied upon a certificate of an officer of the Company and have not independently verified such matters.
We have assumed (i) that each sale of Shares will be duly authorized by the Board of Directors of the Company, a duly authorized committee thereof or a person or body pursuant to an authorization granted in accordance with Section 152 of the General Corporation Law of the State of Delaware (the DGCL), (ii) that no more than 48,503,325 Shares will be sold under the Agreement and (iii) that the price at which the Shares are sold will equal or exceed the par value of the Shares. We express no opinion to the extent that future issuances of securities of the Company and/or anti-dilution adjustments to outstanding securities of the Company cause the number of shares of Common Stock outstanding or issuable upon conversion or exercise of outstanding securities of the Company to exceed the number of Shares then issuable under the Agreement.
Our opinion herein is expressed solely with respect to the DGCL. Our opinion is based on these laws as in effect on the date hereof. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation.
Cooley LLP 11951 Freedom Drive, Reston, VA 20190-5656
t: (703) 456-8000 f: (703) 456-8100 cooley.com
IronNet, Inc.
Page Two
On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued against payment therefor in accordance with the Agreement, the Registration Statement and the Prospectus, will be validly issued, fully paid and nonassessable.
We consent to the reference to our firm under the caption Legal Matters in the Prospectus and to the filing of this opinion as an exhibit to the Registration Statement.
Very truly yours,
COOLEY LLP | ||
By: | /s/ Brian F. Leaf | |
Brian F. Leaf |
Cooley LLP 11951 Freedom Drive, Reston, VA 20190-5656
t: (703) 456-8000 f: (703) 456-8100 cooley.com
Exhibit 10.15
EMPLOYMENT AGREEMENT
This EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of this date of September 6, 2019, by and between IronNet Cybersecurity, Inc., a Delaware corporation (the Company), and James Gerber(Executive). The Company will continue to employ Executive and Executive accepts such continued employment upon the terms and conditions set forth in this Agreement.
1. Term. Executives employment under this Agreement will begin on May 29th, 2019 (Commencement Date) and continue until terminated at the will of either party for any reason or no reason, with or without notice, cause or liability (Term), subject to the terms set forth in Section 4.
2. Duties and Extent of Services.
a. Duties. Executive shall be employed as Chief Financial Officer reporting directly to the Co-Chief Executive Officers or Chief Executive Officer (in either case, the CEO), with such duties and responsibilities as are normally incident to the such title, and such other duties as determined by the CEO.
b. Extent of Services. During the Term, Executive shall devote substantially all of Executives working time and reasonable best efforts to the advancement of the Company and interests of the Company and to the discharge of Executives duties and responsibilities hereunder; provided, however, that nothing in this Agreement shall preclude Executive from devoting reasonable periods required for (i) participating in professional, educational, philanthropic, public interest, charitable, social or community activities, (ii) serving as a director or member of an advisory committee of any corporation or other entity that Executive is serving on as of the Commencement Date or any other corporation or entity that is not in competition with the Company without discussion and consent of the CEO, or (iii) managing his personal investments; provided, further, that any such activities set forth in clauses (i) through (iii) above do not materially interfere with the Executives regular performance of his duties and responsibilities hereunder. Executive shall not engage in any activity which is in any way in conflict with the interests of the Company or that would interfere in any respect with the performance of Executives duties and responsibilities to the Company.
3. Compensation and Benefits
As compensation for all services performed by Executive hereunder during the term, and subject to performance of Executives duties and responsibilities to the Company, pursuant to this Agreement or otherwise:
a. Base Salary and Bonus. The Company shall pay Executive a base salary, at the annualized rate of $340,000 per year, payable in bi-weekly increments in accordance with the Companys normal payroll schedule. Executives base salary may be increased (but not decreased below the original base salary amount) from time to time, subject to the performance of goals and/or milestones established by the Company. Following the end of each fiscal quarter, Executive shall also be eligible for a quarterly bonus of up to 20% of Executives quarterly base salary rate, based upon Executives individual performance during such quarter and the performance during such quarter of the Companys sales teams and the Company overall, as determined by the Company in its sole discretion. At the Companys discretion, such bonus may also be subject to a bonus agreement to be developed by the Company and Executive. In any event, except as otherwise explicitly provided below, Executive must remain an active employee of the Company at the time any bonus is paid in order to be eligible for and to earn a bonus for the quarter to which such payment relates.
b. Equity Awards. Executive shall be eligible to be granted such equity awards following the Commencement Date as the Board shall determine in its sole discretion.
c. Paid Time Off. Executive will continue to be eligible for paid vacation, paid sick days and paid Company holidays consistent with the Companys policies as those policies may be amended from time to time.
d. Benefit Plans. Executive may continue to participate in the benefit programs offered by the Company to its employees from time to time, provided that Executive is eligible under (and subject to all provisions of) the plan documents that govern those programs. Benefits are subject to change at any time in the Companys sole discretion.
e. Expenses. The Executive shall be entitled to receive reimbursement for all reasonable expenses incurred by him during the Term in performing services hereunder, in accordance with the policies and procedures then in effect and established by the Company for its senior executive officers.
4. Severance Benefits (Outside of Change in Control). If Executive is subject to an Involuntary Termination (as defined in Section 4.b below) other than within twelve (12) months following a Change in Control (as defined below), the Company will pay Executive a single lump sum cash severance payment in an amount equal to the sum of (i) six (6) months of Executives base salary and (ii) a prorated quarterly bonus based on the portion of time that Executive worked during the quarter in which the Involuntary Termination occurred (assuming full achievement of relevant target milestones) (with such severance payment subject to all applicable taxes and withholdings). In addition, should Executive timely elect and be eligible to continue receiving group health insurance pursuant to COBRA, the Company will, until the earlier of (x) the date that is six (6) months following the date of Involuntary Termination, and (y) the date on which Executive obtains alternative coverage (as applicable, the COBRA Contribution Period), reimburse Executive on a monthly basis for the full amount of the premiums for such COBRA coverage. To the extent that such reimbursement payments are taxable to Executive, then such reimbursements shall be grossed up by the Company. The remaining balance of any premium costs during the COBRA Contribution Period, and all premium costs thereafter, shall be paid by Executive on a monthly basis for as long as, and to the extent that, Executive remains eligible for COBRA continuation. Executive agrees that, should Executive obtain alternative health insurance coverage prior to the date that is six (6) months following the date of Involuntary Termination, Executive will so inform the Company in writing within five (5) business days of obtaining such coverage.
The foregoing payments are conditioned upon Executive: (i) returning all Company property in Executives possession or control, (ii) resigning from any and all positions Executive holds as an officer of, and/or a member of the Board of Directors of, the Company and all of its subsidiaries, to the extent applicable, and (iii) timely executing (and, if applicable, not revoking) a separation and release of claims agreement in a form materially similar to the form attached as Exhibit A to Employees previous employment agreement dated on or about July 20, 2016 (the Release Agreement), and such Release Agreement becoming irrevocable within 60 days following the date of the Involuntary Termination. The lump sum severance payment shall be made in accordance with the Companys regular payroll practices, on the first payroll date following the date on which the Release Agreement becomes effective and enforceable (the Severance Payment Date), and the COBRA premium reimbursements shall be paid out on a monthly basis in accordance with the Companys regular payroll practices, with the first payment to be made on the Severance Payment Date; provided, however, that if the 60-Day period following the date of Involuntary Termination begins in one calendar year and ends in the following calendar year, no payments hereunder shall be made or commence prior to January 1 of such following calendar year.
a. Termination for Cause. For purposes of this Agreement, Cause means the following: a finding by the Company in good faith that Executive: (i) failed to perform (other than by reason of physical or mental illness or disability for a period of less than three consecutive months or in aggregate less than twenty-six weeks) Executives assigned duties diligently or effectively or was negligent in the performance of these duties, provided that the Executive was given prior written notice of such deficiencies and was granted a reasonable opportunity of not less than fourteen (14) days to correct any such deficiencies; (ii) materially breached this Agreement or any other agreement between Executive and the Company; (iii) engaged in willful misconduct, fraud, or embezzlement; (iv) engaged in any conduct that is, or is reasonably likely to be, materially harmful to the business, interests or reputation of the Company; or (v) was convicted of, or pleaded guilty or nolo contendere to, a misdemeanor relating to the Company, a crime involving moral turpitude, or any felony.
b. Termination for Good Reason. Resignation for Good Reason means a Separation as a result of Executives resignation after one of the following conditions has come into existence without Executives written consent (i) Executives fixed annual compensation (being Executives base salary and non-discretionary bonus, if any) is reduced in aggregate 20% or more compared with Executives fixed annual compensation prior to such change(s), (ii) Executives duties or responsibilities are materially reduced when compared to Executives duties or responsibilities in effect immediately prior to such change, or (iii) the relocation of Executives principal place of business to a location more than fifty (50) miles from such principal location, if such relocation increases Executives daily commuting distance. A Resignation for Good Reason will not be deemed to have occurred unless Executive gives the Company written notice of the condition giving rise to the attempted Resignation for Good Reason within 90 days after the condition comes into existence and the Company fails to remedy the condition within 30 days after receiving such written notice, and Executive resigns for Good Reason within 30 days after the end of the Companys remedy period. Involuntary Termination means either (x) Executives Termination Without Cause or (y) Executives Resignation for Good Reason. Separation means a separation from service, as defined in the regulations under Section 409A of the Code. Termination Without Cause means a Separation as a result of a termination of Executives employment by the Company without Cause, provided Executive is willing and able to continue performing services within the meaning of Treasury Regulation 1.409A-1(n)(1).
c. Standard Termination Benefits. If Executives employment with the Company terminates for any reason, Executive will be entitled to receive, in addition to any other benefits set forth herein: (i) payment of his accrued but unpaid Base Salary then in effect through the date of termination; (ii) any accrued and vested benefits under any compensation and benefit arrangements of the Company in which Executive was a participant on the date of termination, determined in accordance with the applicable terms of such arrangements; and (iii) reimbursement for all reasonable business expenses incurred by Executive in the performance of his duties.
5. Change in Control Benefits:
(a) Change in Control and Involuntary Termination: If there is a Change in Control prior to the termination of Executives employment with the Company and Executive is subject to an Involuntary Termination within 12 months after the Change in Control, then the Company shall pay Executive a single lump sum cash severance payment in an amount equal to the sum of (i) twelve (12) months of Executives base salary and (ii) a full annualized incentive bonus in the amount Executive would have received had Executive worked during the entire year in which the Involuntary Termination occurred (assuming full achievement of relevant target milestones) (with such severance payment subject to all applicable taxes and
withholdings). In addition, should Executive timely elect and be eligible to continue receiving group health insurance pursuant to COBRA, the Company will, until the earlier of (x) the date that is twelve (12) months following the date of Involuntary Termination, and (y) the date on which Executive obtains alternative coverage (as applicable, the COBRA Contribution Period), reimburse Executive on a monthly basis for the full amount of the premiums for such COBRA coverage. To the extent that such reimbursement payments are taxable to Executive, then such reimbursements shall be grossed up by the Company. All premium costs after the COBRA Contribution Period, shall be paid by Executive on a monthly basis for as long as, and to the extent that, Executive remains eligible for COBRA continuation. Executive agrees that, should Executive obtain alternative health insurance coverage prior to the date that is twelve (12) months following the date of Involuntary Termination, Executive will so inform the Company in writing within five (5) business days of obtaining such coverage). In addition, (i) to the extent that the Executive holds any options to acquire common stock of the Company, such options shall become vested in full as of the Severance Payment Date (as defined below) and (ii) to the extent that the Executive holds any Restricted Stock Units (RSUs) in respect of common stock of the Company, the time-based and performance-based vesting requirements of the RSUs will be deemed to have been satisfied in full effective as of the Severance Payment Date, provided that (A) with respect to any RSUs granted to the Executive prior to the Commencement Date, the satisfaction of the time-based and performance-based vesting requirements shall not change the time at which shares of Company common stock are delivered under the RSU and for purposes of determining such delivery, the Executive shall be deemed to have continued to perform services on each applicable vesting date and (B) with respect to any RSUs granted to Executive following the Commencement Date, for any Involuntary Termination following the Change in Control, the shares subject to the RSU that have not satisfied the time-based vesting requirement as of the date of the Involuntary Termination shall be delivered promptly following (and no more than 10 days) later than the satisfaction of the requirements in the following sentence.
The foregoing payments are conditioned upon Executive: (i) returning all Company property in Executives possession or control, (ii) resigning from any and all positions Executive holds as an officer of, and/or a member of the Board of Directors of, the Company and all of its subsidiaries, to the extent applicable, and (iii) timely executing (and, if applicable, not revoking) a form materially similar to the form of Release Agreement (defined in 4 above), and such Release Agreement becoming irrevocable within 60 days following the date of the Involuntary Termination. The lump sum severance payment shall be made in accordance with the Companys regular payroll practices, on the first payroll date following the date on which the Release Agreement becomes effective and enforceable (the Severance Payment Date), and the COBRA premium reimbursements shall be paid out on a monthly basis in accordance with the Companys regular payroll practices, with the first payment to be made on the Severance Payment Date; provided, however, that if the 60-Day period following the date of Involuntary Termination begins in one calendar year and ends in the following calendar year, no payments hereunder shall be made or commence prior to January 1 of such following calendar year.
(b) For purposes of this Agreement, Change in Control shall mean the consummation of any of the following transactions pursuant to a bona fide offer by an unrelated third party that is not an affiliate of the Company in a single transaction or series of related transactions: (i) the sale or issuance of equity interests of the Company to any unrelated third party (other than (A) a person who is an existing equity holder, (B) any trust, partnership or corporation controlled by an existing equity holder, (C) any employee benefit plan of the Company or any affiliate, or any entity holding equity for or pursuant to the terms of any such employee benefit plan), such that the equity holders of the Company immediately prior to such transaction and their respective affiliates hold less than a majority (i.e., less than 50%) of the total fair market value or total voting power of the then issued and outstanding voting equity interests of the Company immediately following such transaction; (ii) the consummation of a merger of the Company with or into another person if more than one-half of the combined voting power of the continuing or surviving persons securities outstanding immediately after the merger is owned by persons who were not equity holders or affiliates of
equity holders of the Company immediately before the merger; or (iii) the sale, transfer or other disposition of all or substantially all of the assets of the Company and its affiliates, taken as a whole, excluding for purposes of (i), (ii), and (iii) above, any grant of security interests in any equity securities or assets of the Company or any affiliates of the Company. Notwithstanding anything herein to the contrary, no event or transaction or series of events or transactions shall constitute a Change in Control unless such event or transaction or series of events or transactions constitutes a change in control event within the meaning of Treasury Regulation 1.409A-3(i).
6. Protection of Confidential Information. Executive recognizes that by virtue of Executives employment with the Company, Executive will be granted otherwise prohibited access to trade secrets and other confidential and proprietary information which is not known to the Companys competitors or within the Companys industry generally, which was developed by the Company over a long period of time and/or at substantial expense, and which is confidential in nature or otherwise of great competitive value to the Company (Confidential Information). Confidential Information includes, but is not limited to, trade secrets, information relating to the Companys practices and methods of doing business; sales, marketing, and service strategies, programs, technologies, and procedures; customers and prospective customers, including, but not limited to, their particularized requirements and preferences, their product specifications, the identity and authority of their key contact persons, payment methods, and order histories and patterns; service, product and material costs; pricing structures; bids; responses to requests for proposals; bonus and incentive plans; vendors and sources of supply; financial position and business plans; computer programs and databases; research projects; new product and service developments; compositions, formulas, patterns, compilations, programs, techniques, devices, processes, plans, designs, and drawings; and any other information of the Company, its affiliates, or any of its vendors or customers, which the Company informs Executive, or which Executive should know by virtue of Executives position or the circumstances in which Executive learned it, is to be kept confidential. Confidential Information does not include information that is publicly available or otherwise known in the industry but not as a result of Executives violation of his obligations under this Agreement. Nothing in this Agreement shall prohibit or impede Executive from communicating, cooperating or filing a complaint with any U.S. federal, state or local governmental or law enforcement branch, agency or entity (collectively, a Governmental Entity) with respect to possible violations of U.S. federal, state or local law or regulation, or otherwise making disclosures to any Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided that in each case such communications and disclosures are consistent with applicable law. Executive does not need prior authorization (or to give notice to) the Company regarding any such communication or disclosure. Notwithstanding the foregoing, under no circumstance is Executive authorized to disclose any information covered by the Companys attorney-client privilege or attorney work product.
(i) Executive will not, at any time during or after Executives employment with the Company, disclose, use or permit others to use any Confidential Information, except as required in the course of Executives employment for the benefit of the Company.
(ii) Executive will take all reasonable measures during and after Executives employment with the Company to protect the Confidential Information from any accidental or unauthorized disclosure or use.
(iii) Notwithstanding Executives confidentiality and nondisclosure obligations as set forth above, Executive is hereby advised as follows pursuant to the Defend Trade Secrets Act: An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.
7. Return of Property. Upon the voluntary or involuntary termination of Executives employment with the Company, or at any time requested by the Company, Executive shall return to the Company all literature, correspondence, memoranda, reports, summaries, manuals, proposals, contracts, documents, computer disks and other electronic storage media, computer programs, mobile/smart phones, pagers, computers, and other materials and equipment of any kind which relate to the business of the Company, including specifically, but not exclusively, all materials which comprise or refer to the Companys Confidential Information. It is understood and agreed that all such materials are, and will remain, the exclusive property of the Company and that Executive will not retain any copy, facsimile or note memorializing any such materials or the contents thereof. Further while employed by the Company, Executive shall not, except for the benefit of the Company, use, copy or duplicate any Company documents or other materials.
8. Developments. Executive agrees as follows with regard to any developments that relate to the Companys business or Confidential Information, or that Executive conceives, makes, develops or acquires during the term of his employment with the Company and within the scope of his/her employment by the Company, including, but not limited to, any trade secrets, discoveries, inventions, improvements, ideas, programs, formulas, diagrams, designs, plans and drawings, whether or not reduced to writing, patented, copyrighted or trademarked (Developments):
(i) Executive shall promptly and fully disclose all Developments to the Company, and shall prepare, maintain, and make available to the Company adequate and current written records of such Developments and all modifications, research, and studies made or undertaken by Executive with respect thereto.
(ii) All Developments and related records shall become and remain the exclusive property of the Company and, to the extent Executive has any rights thereto, Executive hereby assigns all such rights, title, and interest to the Company and waives any moral rights he/she may have in any Developments.
(iii) Upon request by the Company, the Executive at any time, whether during or after his employment by the Company, shall execute, acknowledge and deliver to the Company, all assignments and other documents which the Company deems necessary or desirable to: (a) vest the Company with full and exclusive right, title, and interest to such Developments, and (b) enable the Company to file and prosecute an application for, or acquire, maintain or enforce, all letters of patent, trademark registrations, and copyrights covering such Developments.
(iv) Executive understands that the foregoing provisions regarding assignments do not apply to any Developments for which no equipment, supplies, facility or trade secret information of the Company was used, and which were developed entirely on Employees own time, unless the Developments: (a) relate to the Companys business or to its actual or demonstrably anticipated research or development, or (b) result from any work performed by Executive for the Company.
Notwithstanding the foregoing provisions of this Section 8, the parties acknowledge and agree that, subject to the Executives ongoing obligations to protect the Companys Confidential Information under Section 6 above, the Executives own proprietary Sales Methodology, Operations Control Book and other product/practices/processes related to the foregoing and their derivate works are recognized as prior inventions of Executive and not Developments for purposes of this Agreement.
9. Restrictions on Solicitation and Competition. Executive recognizes that by virtue of Executives employment with the Company, he may be introduced to and extensively involved in the servicing of long-standing customers of the Company; that he may be extensively involved in soliciting and servicing new customers identified, developed and/or secured by the Company during his employment; and that he may be afforded numerous and extensive resources to assist him in soliciting and servicing such customers. Executive understands and agrees that all efforts expended in soliciting and servicing the Companys customers shall be for the exclusive benefit of the Company; that the Company shall secure and retain a proprietary interest in all such customers; and that Executive will not, during the Restricted Period, knowingly undertake any action which could reasonably be expected to disturb the Companys relationship with its customers in any material respect. Executive acknowledges the Companys legitimate interest in protecting its Confidential Information, customer relationships, referral relationships and general goodwill during Executives employment with the Company and for a reasonable period of time following the termination of Executives employment with the Company. Accordingly, Executive agrees that, during his employment with the Company and for a period of one (1) year following the voluntary or involuntary termination of his employment for any reason (the Restricted Period):
(i) Executive will not, directly or indirectly, without the express written consent of the Company, hire, employ, engage, or attempt to hire, employ or engage any Company Employee, or otherwise solicit, request, entice, or induce any Company Employee to terminate his/her or her employment or engagement with the Company, for the purpose of engaging in business activities that are competitive with the Companys business activities. The term Company Employee means an employee of the Company with whom Executive interacted for business purposes at any time during the six (6) month period immediately preceding the termination of Executives employment with the Company and who was employed by the Company at any time within the last sixty (60) days of Executives employment with the Company.
(ii) Executive will not directly or indirectly, solicit or accept business from any Company Customer, where such business would be competitive with the Companys business or services. The term Company Customer means (i) any customer of the Company to whom Executive played a role in selling, rendering or providing the Companys services at any time during the one (1) year period immediately preceding the termination of his employment; (ii) any entity for which Executive orchestrated, developed, supervised, coordinated or participated in marketing strategy, marketing plans and marketing campaigns; bid submissions; or responses to requests for proposals on behalf of the Company at any time during the one (1) year period immediately preceding the termination of his employment; or (iii) any entity as to which Executive acquired Confidential Information at any time during his employment with the Company.
(iii) Executive will not, on his own behalf, or through acceptance of any consulting engagement, assignment or employment with any third party, compete against the Company for work under any government contract held by the Company at any time during the Restricted Period, or under any re-compete, re-bid, extension or modification thereof. Nothing in this paragraph is intended to restrict Executive from accepting any consulting engagement, assignment or employment with any third party, including any Company Customer, to provide services that would not compete with the Companys business or services.
(iv) Executive will not directly or indirectly, knowingly interfere, or attempt to interfere with any relationship the Company has with any of its vendors or suppliers in any material respect.
10. Reasonableness of Restrictions. Executive acknowledges that the restrictions set forth in Sections 6, 7, 8, and 9 of this Agreement are reasonable to protect the Companys legitimate business interests and that such restrictions do impose an undue burden on Executive. Executive further agrees that his breach of Sections 6, 7, 8 or 9 of this Agreement would cause the Company immediate and irreparable harm and that the Company may pursue preliminary and permanent injunctive relief to enforce Sections 6, 7, 8 or 9.
11. Assignment. All of the provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective heirs, executors, administrators, personal representatives, successors and assigns of the parties hereto, except that the duties and responsibilities of Executive hereunder are of a personal nature and shall not be assignable or delegable by Executive.
12. Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.
13. Amendment, Waiver. Neither Executive nor the Company may modify, amend, or waive the terms of this Agreement other than by a written instrument signed by Executive and the Company. Either partys waiver of the other partys compliance with any specific provision of this Agreement is not a waiver of any other provision of this Agreement or of any subsequent breach by such party of a provision of this Agreement. No delay on the part of any party in exercising any right, power or privilege hereunder will operate as a waiver thereof.
14. Notices. Any and all notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be effective when delivered in person, consigned to a reputable national courier service or deposited in the United States mail, postage prepaid, registered or certified, and addressed to Executive at Executives last known address on the books of the Company or, in the case of the Company, at its principal place of business, attention of the Manager of the Company, or to such other address as either party may specify by notice to the other actually received.
15. Entire Agreement. This Agreement constitutes the entire agreement between the parties and supersedes and terminates all prior communications, agreements and understandings, written or oral, with respect to the terms and conditions of Executives employment with the Company, including, without limitation, the Executive Employment Agreement between Executive and the Company dated July 20, 2016, provided that any outstanding Company equity awards shall remain subject to the applicable equity award agreement with only the specific modifications set forth herein. By entering into this Agreement, Executive certifies and acknowledges that Executive has carefully read all of the provisions of this Agreement, and that Executive voluntarily and knowingly enters into said Agreement.
16. Advice of Counsel and Construction. The parties acknowledge that all parties to this Agreement have been represented by counsel, or had the opportunity to be represented by counsel of their choice. Accordingly, the rule of construction of contract language against the drafting party is hereby waived by all parties. Additionally, neither the drafting history nor the negotiating history of this Agreement may be used or referred to in connection with the construction or interpretation of this Agreement.
17. Governing Law. This is a Maryland contract and shall be construed and enforced under and be governed in all respects by the laws of the State of Maryland, without regard to the conflict of laws principles thereof.
18. Effect of Excise Tax and Limit on Golden Parachute Payments.
(a) Contingent Reduction of Parachute Payments. If there is a change in ownership or control of the Company that would cause any payment or distribution by the Company or any of its subsidiaries or any other person or entity to the Executive or for the Executives benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise) (each, a Payment, and collectively, the Payments) to be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code (the Code) (such excise tax, together with any interest or penalties incurred by the Executive with respect to such excise tax, the Excise Tax), then the Executive will receive the greatest of the following, whichever gives the Executive the highest net after-tax amount (after taking into account federal, state, local and social security taxes): (1) the Payments or (2) one dollar less than the amount of the Payments that would subject the Executive to the Excise Tax (the Safe Harbor Amount). If a reduction in the Payments is necessary so that the Payments equal the Safe Harbor Amount, then the reduction will be determined in a manner which has the least economic cost to the Executive and, to the extent the economic cost is equivalent, will be reduced in the inverse order of when payment would have been made to the Executive, until the reduction is achieved. Any reductions pursuant to this Section shall be made in a manner intended to be consistent with the requirements of Section 409A of the Code and the Department of Treasury Regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidelines that may be issued after the Commencement Date (Section 409A).
(b) Determination of the Payments. All determinations required to be made under this Section 9, including whether and when the Safe Harbor Amount is required and the amount of the reduction of the Payments and the assumptions to be utilized in arriving at such determination, shall be made by a certified public accounting firm or national law firm designated by Company (the Accounting Firm) which shall provide detailed supporting calculations both to the Company and the Executive within fifteen (15) business days of the receipt of notice from the Executive that there has been a Payment, or such earlier time as is requested by the Company. All fees and expenses of the Accounting Firm shall be borne solely by the Company. Any determination by the Accounting Firm shall be binding upon the Company and the Executive. The Executive shall cooperate with any reasonable requests by the Company in connection with any contests or disputes with the Internal Revenue Service in connection with the Excise Tax.
(c) Adjustments. As a result of the uncertainty in the application of Section 4999 of the Code at the time of a determination hereunder, it is possible that Payments will be made which should not have been made under clause (a) of this Section 18 (Overpayment) or that additional Payments which are not made pursuant to clause (a) of this Section 18 should have been made (Underpayment). In the event that there is a final determination by the Internal Revenue Service, or a final determination by a court of competent jurisdiction, that an Overpayment has been made, any such Overpayment shall be treated for all purposes as a loan to the Executive which the Executive shall repay to Company together with interest at the applicable Federal rate provided in Section 7872(f)(2) of the Code. In the event that there is a final determination by the Internal Revenue Service or a court of competent jurisdiction or a change in the provisions of the Code or regulations pursuant to which an Underpayment arises under this Agreement, any such Underpayment shall be promptly paid by Company to or for the benefit of the Executive, together with interest at the applicable Federal rate provided in Section 7872(f)(2) of the Code.
(d) Consultation. The Company shall consult with the Executive in good faith regarding the implementation of the provisions of this Section 18 and the application of Sections 4999 and 409A of the Code; provided, that neither the Company nor any of its subsidiaries, employees or representatives shall have any liability to the Executive with respect thereto.
IN WITNESS WHEREOF, this Agreement has been executed by the Company, by its duly authorized representative, and by Executive, as of the date first above written.
IronNet Cybersecurity, Inc. | ||||
By: | /s/ William Welch | Date: 9/13/2019 | ||
Name: Title: |
William Welch Co-CEO |
|||
Executive | ||||
James Gerber: | /s/ James Gerber | Date: 9/11/2019 |
Exhibit 10.16
EMPLOYMENT AGREEMENT
This EMPLOYMENT AGREEMENT (this Agreement) is made and entered into as of this date of September 19, 2019 by and between IronNet Cybersecurity, Inc., a Delaware corporation (the Company), and Donald Closser (Executive). The Company will continue to employ Executive and Executive accepts such continued employment upon the terms and conditions set forth in this Agreement.
1. Term. Executives employment under this Agreement will begin on October 21, 2019 (Commencement Date) and continue until terminated at the will of either party for any reason or no reason, with or without notice, cause or liability (Term), subject to the terms set forth in Section 4.
2. Duties and Extent of Services.
a. Duties. Executive shall be employed as Chief Product Officer reporting directly to the Co-Chief Executive Officers or Chief Executive Officer (in either case, the CEO), with such duties and responsibilities as are normally incident to the such title, and such other duties as determined by the CEO.
b. Extent of Services. During the Term, Executive shall devote substantially all of Executives working time and reasonable best efforts to the advancement of the Company and interests of the Company and to the discharge of Executives duties and responsibilities hereunder; provided, however, that nothing in this Agreement shall preclude Executive from devoting reasonable periods required for (i) participating in professional, educational, philanthropic, public interest, charitable, social or community activities, (ii) serving as a director or member of an advisory committee of any corporation or other entity that Executive is serving on as of the Commencement Date or any other corporation or entity that is not in competition with the Company without discussion and consent of the CEO, or (iii) managing his personal investments; provided, further, that any such activities set forth in clauses (i) through (iii) above do not materially interfere with the Executives regular performance of his duties and responsibilities hereunder. Executive shall not engage in any activity which is in any way in conflict with the interests of the Company or that would interfere in any respect with the performance of Executives duties and responsibilities to the Company.
3. Compensation and Benefits
As compensation for all services performed by Executive hereunder during the term, and subject to performance of Executives duties and responsibilities to the Company, pursuant to this Agreement or otherwise:
a. Base Salary and Bonus. The Company shall pay Executive a base salary, at the annualized rate of $330,000 per year, payable in bi-weekly increments in accordance with the Companys normal payroll schedule. Executives base salary may be increased (but not decreased below the original base salary amount) from time to time, subject to the performance of goals and/or milestones established by the Company. Following the end of each fiscal quarter, Executive shall also be eligible for a quarterly bonus of up to 20% of Executives quarterly base salary rate, based upon Executives individual performance during such quarter and the performance during such quarter of the Companys sales teams and the Company overall, as determined by the Company in its sole discretion. At the Companys discretion, such bonus may also be subject to a bonus agreement to be developed by the Company and Executive. In any event, except as otherwise explicitly provided below, Executive must remain an active employee of the Company at the time any bonus is paid in order to be eligible for and to earn a bonus for the quarter to which such payment relates.
1
b. Equity Awards. Executive shall be eligible to be granted such equity awards following the Commencement Date. Executive shall be granted 750,000 Restricted Stock Units on the Commencement Date and additional equity awards as the Board shall determine in its sole discretion.
d. Paid Time Off. Executive will continue to be eligible for paid vacation, paid sick days and paid Company holidays consistent with the Companys policies as those policies may be amended from time to time.
e. Benefit Plans. Executive may continue to participate in the benefit programs offered by the Company to its employees from time to time, provided that Executive is eligible under (and subject to all provisions of) the plan documents that govern those programs. Benefits are subject to change at any time in the Companys sole discretion.
f. Expenses. The Executive shall be entitled to receive reimbursement for all reasonable expenses incurred by him during the Term in performing services hereunder, in accordance with the policies and procedures then in effect and established by the Company for its senior executive officers. Executive will also be allowed Business Class travel overseas.
4. Severance Benefits (Outside of Change in Control). If Executive is subject to an Involuntary Termination (as defined in Section 4.b below) other than within twelve (12) months following a Change in Control (as defined below), the Company will pay Executive a single lump sum cash severance payment in an amount equal to the sum of (i) six (6) months of Executives base salary and (ii) a prorated quarterly bonus based on the portion of time that Executive worked during the quarter in which the Involuntary Termination occurred (assuming full achievement of relevant target milestones) (with such severance payment subject to all applicable taxes and withholdings). In addition, should Executive timely elect and be eligible to continue receiving group health insurance pursuant to COBRA, the Company will, until the earlier of (x) the date that is six (6) months following the date of Involuntary Termination, and (y) the date on which Executive obtains alternative coverage (as applicable, the COBRA Contribution Period), reimburse Executive on a monthly basis for the full amount of the premiums for such COBRA coverage. To the extent that such reimbursement payments are taxable to Executive, then such reimbursements shall be grossed up by the Company. All premium costs after the COBRA Contribution Period, shall be paid by Executive on a monthly basis for as long as, and to the extent that, Executive remains eligible for COBRA continuation. Executive agrees that, should Executive obtain alternative health insurance coverage prior to the date that is six (6) months following the date of Involuntary Termination, Executive will so inform the Company in writing within five (5) business days of obtaining such coverage.
The foregoing payments are conditioned upon Executive: (i) returning all Company property in Executives possession or control, (ii) resigning from any and all positions Executive holds as an officer of, and/or a member of the Board of Directors of, the Company and all of its subsidiaries, to the extent applicable, and (iii) timely executing (and, if applicable, not revoking) a separation and release of claims agreement in a form to be provided by the Company (the Release Agreement), and such Release Agreement becoming irrevocable within 60 days following the date of the Involuntary Termination. The lump sum severance payment shall be made in accordance with the Companys regular payroll practices, on the first payroll date following the date on which the Release Agreement becomes effective and enforceable (the Severance Payment Date), and the COBRA premium reimbursements shall be paid out on a monthly basis in accordance with the Companys regular payroll practices, with the first payment to be made on the Severance Payment Date; provided, however, that if the 60-Day period following the date of Involuntary Termination begins in one calendar year and ends in the following calendar year, no payments hereunder shall be made or commence prior to January 1 of such following calendar year.
2
a. Termination for Cause. For purposes of this Agreement, Cause means the following: a finding by the Company in good faith that Executive: (i) failed to perform (other than by reason of physical or mental illness or disability for a period of less than three consecutive months or in aggregate less than twenty-six weeks) Executives assigned duties diligently or effectively or was negligent in the performance of these duties, provided that the Executive was given prior written notice of such deficiencies and was granted a reasonable opportunity of not less than fourteen (14) days to correct any such deficiencies; (ii) materially breached this Agreement or any other agreement between Executive and the Company; (iii) engaged in willful misconduct, fraud, or embezzlement; (iv) engaged in any conduct that is, or is reasonably likely to be, materially harmful to the business, interests or reputation of the Company; or (v) was convicted of, or pleaded guilty or nolo contendere to, a misdemeanor relating to the Company, a crime involving moral turpitude, or any felony.
b. Termination for Good Reason/Involuntary Termination. Resignation for Good Reason means a Separation as a result of Executives resignation after one of the following conditions has come into existence without Executives written consent (i) Executives fixed annual compensation (being Executives base salary and non-discretionary bonus, if any) is reduced 20% or more compared with Executives fixed annual compensation prior to such change, (ii) Executives duties or responsibilities are materially reduced when compared to Executives duties or responsibilities in effect immediately prior to such change, or (iii) the relocation of Executives principal place of business which is Leander, Texas, to a location more than fifty (50) miles from such principal location. A Resignation for Good Reason will not be deemed to have occurred unless Executive gives the Company written notice of the condition giving rise to the attempted Resignation for Good Reason within 90 days after the condition comes into existence and the Company fails to remedy the condition within 30 days after receiving such written notice, and Executive resigns for Good Reason within 30 days after the end of the Companys remedy period. Involuntary Termination means either (x) Executives Termination Without Cause or (y) Executives Resignation for Good Reason. Separation means a separation from service, as defined in the regulations under Section 409A of the Code. Termination Without Cause means a Separation as a result of a termination of Executives employment by the Company without Cause, provided Executive is willing and able to continue performing services within the meaning of Treasury Regulation 1.409A-1(n)(1).
c. Standard Termination Benefits. If Executives employment with the Company terminates for any reason, Executive will be entitled to receive, in addition to any other benefits set forth herein: (i) payment of his accrued but unpaid Base Salary then in effect through the date of termination; (ii) any accrued and vested benefits under any compensation and benefit arrangements of the Company in which Executive was a participant on the date of termination, determined in accordance with the applicable terms of such arrangements; and (iii) reimbursement for all reasonable business expenses incurred by Executive in the performance of his duties.
5. Change in Control Benefits:
(a) Change in Control and Involuntary Termination: If there is a Change in Control prior to the termination of Executives employment with the Company and Executive is subject to an Involuntary Termination within 12 months after the Change in Control, then the Company shall pay Executive a single lump sum cash severance payment in an amount equal to the sum of (i) twelve (12) months of Executives base salary and (ii) a full annualized incentive bonus in the amount Executive would have received had Executive worked during the entire year in which the Involuntary Termination occurred (assuming full achievement of relevant target milestones) (with such severance payment subject to all applicable taxes and withholdings). In addition, should Executive timely elect and be eligible to continue receiving group health insurance pursuant to COBRA, the Company will, until the earlier of (x) the date that is twelve (12) months following the date of Involuntary Termination, and (y) the date on which Executive obtains alternative coverage (as applicable, the COBRA Contribution Period), reimburse
3
Executive on a monthly basis for the full amount of the premiums for such COBRA coverage. To the extent that such reimbursement payments are taxable to Executive, then such reimbursements shall be grossed up by the Company. All premium costs after the COBRA Contribution Period, shall be paid by Executive on a monthly basis for as long as, and to the extent that, Executive remains eligible for COBRA continuation. Executive agrees that, should Executive obtain alternative health insurance coverage prior to the date that is twelve (12) months following the date of Involuntary Termination, Executive will so inform the Company in writing within five (5) business days of obtaining such coverage. In addition, (i) to the extent that the Executive holds any options to acquire common stock of the Company, such options shall become vested in full as of the Severance Payment Date (as defined below) and (ii) to the extent that the Executive holds any Restricted Stock Units (RSUs) in respect of common stock of the Company, the time-based and performance-based vesting requirements of the RSUs will be deemed to have been satisfied in full effective as of the Severance Payment Date, provided that (A) with respect to any RSUs granted to the Executive prior to the Commencement Date, the satisfaction of the time-based and performance-based vesting requirements shall not change the time at which shares of Company common stock are delivered under the RSU and for purposes of determining such delivery, the Executive shall be deemed to have continued to perform services on each applicable vesting date and (B) with respect to any RSUs granted to Executive following the Commencement Date, for any Involuntary Termination following the Change in Control, the shares subject to the RSU that have not satisfied the time-based vesting requirement as of the date of the Involuntary Termination shall be delivered promptly following (and no more than 10 days) later than the satisfaction of the requirements in the following sentence.
The foregoing payments are conditioned upon Executive: (i) returning all Company property in Executives possession or control, (ii) resigning from any and all positions Executive holds as an officer of, and/or a member of the Board of Directors of, the Company and all of its subsidiaries, to the extent applicable, and (iii) timely executing (and, if applicable, not revoking) a separation and release of claims agreement in a form to be provided by the Company (the Release Agreement), and such Release Agreement becoming irrevocable within 60 days following the date of the Involuntary Termination. The lump sum severance payment shall be made in accordance with the Companys regular payroll practices, on the first payroll date following the date on which the Release Agreement becomes effective and enforceable (the Severance Payment Date), and the COBRA premium reimbursements shall be paid out on a monthly basis in accordance with the Companys regular payroll practices, with the first payment to be made on the Severance Payment Date; provided, however, that if the 60-Day period following the date of Involuntary Termination begins in one calendar year and ends in the following calendar year, no payments hereunder shall be made or commence prior to January 1 of such following calendar year.
(b) For purposes of this Agreement, Change in Control shall mean the consummation of any of the following transactions pursuant to a bona fide offer by an unrelated third party that is not an affiliate of the Company in a single transaction or series of related transactions: (i) the sale or issuance of equity interests of the Company to any unrelated third party (other than (A) a person who is an existing equity holder, (B) any trust, partnership or corporation controlled by an existing equity holder, (C) any employee benefit plan of the Company or any affiliate, or any entity holding equity for or pursuant to the terms of any such employee benefit plan), such that the equity holders of the Company immediately prior to such transaction and their respective affiliates hold less than a majority (i.e., less than 50%) of the total fair market value or total voting power of the then issued and outstanding voting equity interests of the Company immediately following such transaction; (ii) the consummation of a merger of the Company with or into another person if more than one-half of the combined voting power of the continuing or surviving persons securities outstanding immediately after the merger is owned by persons who were not equity holders or affiliates of equity holders of the Company immediately before the merger; or (iii) the sale, transfer or other disposition of all or substantially all of the assets of the Company and its affiliates, taken as a whole, excluding for purposes of (i), (ii), and (iii) above, any grant of security interests in any equity securities or assets of the Company or any affiliates of the Company. Notwithstanding anything
4
herein to the contrary, no event or transaction or series of events or transactions shall constitute a Change in Control unless such event or transaction or series of events or transactions constitutes a change in control event within the meaning of Treasury Regulation 1.409A-3(i).
6. Protection of Confidential Information. Executive recognizes that by virtue of Executives employment with the Company, Executive will be granted otherwise prohibited access to trade secrets and other confidential and proprietary information which is not known to the Companys competitors or within the Companys industry generally, which was developed by the Company over a long period of time and/or at substantial expense, and which is confidential in nature or otherwise of great competitive value to the Company (Confidential Information). Confidential Information includes, but is not limited to, trade secrets, information relating to the Companys practices and methods of doing business; sales, marketing, and service strategies, programs, technologies, and procedures; customers and prospective customers, including, but not limited to, their particularized requirements and preferences, their product specifications, the identity and authority of their key contact persons, payment methods, and order histories and patterns; service, product and material costs; pricing structures; bids; responses to requests for proposals; bonus and incentive plans; vendors and sources of supply; financial position and business plans; computer programs and databases; research projects; new product and service developments; compositions, formulas, patterns, compilations, programs, techniques, devices, processes, plans, designs, and drawings; and any other information of the Company, its affiliates, or any of its vendors or customers, which the Company informs Executive, or which Executive should know by virtue of Executives position or the circumstances in which Executive learned it, is to be kept confidential. Confidential Information does not include information that is publicly available or otherwise known in the industry but not as a result of Executives violation of his obligations under this Agreement. Nothing in this Agreement shall prohibit or impede Executive from communicating, cooperating or filing a complaint with any U.S. federal, state or local governmental or law enforcement branch, agency or entity (collectively, a Governmental Entity) with respect to possible violations of U.S. federal, state or local law or regulation, or otherwise making disclosures to any Governmental Entity, in each case, that are protected under the whistleblower provisions of any such law or regulation, provided that in each case such communications and disclosures are consistent with applicable law. Executive does not need prior authorization (or to give notice to) the Company regarding any such communication or disclosure. Notwithstanding the foregoing, under no circumstance is Executive authorized to disclose any information covered by the Companys attorney-client privilege or attorney work product.
(i) Executive will not, at any time during or after Executives employment with the Company, disclose, use or permit others to use any Confidential Information, except as required in the course of Executives employment for the benefit of the Company.
(ii) Executive will take all reasonable measures during and after Executives employment with the Company to protect the Confidential Information from any accidental or unauthorized disclosure or use.
(iii) Notwithstanding Executives confidentiality and nondisclosure obligations as set forth above, Executive is hereby advised as follows pursuant to the Defend Trade Secrets Act: An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that (A) is made (i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.
5
7. Return of Property. Upon the voluntary or involuntary termination of Executives employment with the Company, or at any time requested by the Company, Executive shall return to the Company all literature, correspondence, memoranda, reports, summaries, manuals, proposals, contracts, documents, computer disks and other electronic storage media, computer programs, mobile/smart phones, pagers, computers, and other materials and equipment of any kind which relate to the business of the Company, including specifically, but not exclusively, all materials which comprise or refer to the Companys Confidential Information. It is understood and agreed that all such materials are, and will remain, the exclusive property of the Company and that Executive will not retain any copy, facsimile or note memorializing any such materials or the contents thereof. Further while employed by the Company, Executive shall not, except for the benefit of the Company, use, copy or duplicate any Company documents or other materials.
8. Developments. Executive agrees as follows with regard to any developments that relate to the Companys business or Confidential Information, or that Executive conceives, makes, develops or acquires during the term of his employment with the Company and within the scope of his/her employment by the Company, including, but not limited to, any trade secrets, discoveries, inventions, improvements, ideas, programs, formulas, diagrams, designs, plans and drawings, whether or not reduced to writing, patented, copyrighted or trademarked (Developments):
(i) Executive shall promptly and fully disclose all Developments to the Company, and shall prepare, maintain, and make available to the Company adequate and current written records of such Developments and all modifications, research, and studies made or undertaken by Executive with respect thereto.
(ii) All Developments and related records shall become and remain the exclusive property of the Company and, to the extent Executive has any rights thereto, Executive hereby assigns all such rights, title, and interest to the Company and waives any moral rights he/she may have in any Developments.
(iii) Upon request by the Company, the Executive at any time, whether during or after his employment by the Company, shall execute, acknowledge and deliver to the Company, all assignments and other documents which the Company deems necessary or desirable to: (a) vest the Company with full and exclusive right, title, and interest to such Developments, and (b) enable the Company to file and prosecute an application for, or acquire, maintain or enforce, all letters of patent, trademark registrations, and copyrights covering such Developments.
(i) Executive understands that the foregoing provisions regarding assignments do not apply to any Developments for which no equipment, supplies, facility or trade secret information of the Company was used, and which were developed entirely on Employees own time, unless the Developments: (a) relate to the Companys business or to its actual or demonstrably anticipated research or development, or (b) result from any work performed by Executive for the Company.
Notwithstanding the foregoing provisions of this Section 8, the parties acknowledge and agree that, subject to the Executives ongoing obligations to protect the Companys Confidential Information under Section 6 above, the Executives own proprietary Sales Methodology, Operations Control Book and other product/practices/processes related to the foregoing and their derivate works are recognized as prior inventions of Executive and not Developments for purposes of this Agreement.
6
9. Restrictions on Solicitation and Competition. Executive recognizes that by virtue of Executives employment with the Company, he may be introduced to and extensively involved in the servicing of long-standing customers of the Company; that he may be extensively involved in soliciting and servicing new customers identified, developed and/or secured by the Company during his employment; and that he may be afforded numerous and extensive resources to assist him in soliciting and servicing such customers. Executive understands and agrees that all efforts expended in soliciting and servicing the Companys customers shall be for the exclusive benefit of the Company; that the Company shall secure and retain a proprietary interest in all such customers; and that Executive will not, during the Restricted Period, knowingly undertake any action which could reasonably be expected to disturb the Companys relationship with its customers in any material respect. Executive acknowledges the Companys legitimate interest in protecting its Confidential Information, customer relationships, referral relationships and general goodwill during Executives employment with the Company and for a reasonable period of time following the termination of Executives employment with the Company. Accordingly, Executive agrees that, during his employment with the Company and for a period of one (1) year following the voluntary or involuntary termination of his employment for any reason (the Restricted Period):
(i) Executive will not, directly or indirectly, without the express written consent of the Company, hire, employ, engage, or attempt to hire, employ or engage any Company Employee, or otherwise solicit, request, entice, or induce any Company Employee to terminate his/her or her employment or engagement with the Company, for the purpose of engaging in business activities that are competitive with the Companys business activities. The term Company Employee means an employee of the Company with whom Executive interacted for business purposes at any time during the six (6) month period immediately preceding the termination of Executives employment with the Company and who was employed by the Company at any time within the last sixty (60) days of Executives employment with the Company.
(ii) Executive will not directly or indirectly, solicit or accept business from any Company Customer, where such business would be reasonably construed to be competitive with the Companys business or services. The term Company Customer means (i) any customer of the Company to whom Executive played a role in selling, rendering or providing the Companys services at any time during the one (1) year period immediately preceding the termination of his employment; (ii) any entity for which Executive orchestrated, developed, supervised, coordinated or participated in marketing strategy, marketing plans and marketing campaigns; bid submissions; or responses to requests for proposals on behalf of the Company at any time during the one (1) year period immediately preceding the termination of his employment; or (iii) any entity as to which Executive acquired Confidential Information at any time during his employment with the Company.
(iii) Executive will not, on his own behalf, or through acceptance of any consulting engagement, assignment or employment with any third party, reasonably construed to be competitive against the Company for work under any government contract held by the Company at any time during the Restricted Period, or under any re-compete, re-bid, extension or modification thereof. Nothing in this paragraph is intended to restrict Executive from accepting any consulting engagement, assignment or employment with any third party, including any Company Customer, to provide services that would not compete with the Companys business or services.
(iv) Executive will not directly or indirectly, knowingly interfere, or attempt to interfere with any relationship the Company has with any of its vendors or suppliers in any material respect.
7
10. Reasonableness of Restrictions. Executive acknowledges that the restrictions set forth in Sections 6, 7, 8, and 9 of this Agreement are reasonable to protect the Companys legitimate business interests and that such restrictions do impose an undue burden on Executive. Executive further agrees that his breach of Sections 6, 7, 8 or 9 of this Agreement would cause the Company immediate and irreparable harm and that the Company may pursue preliminary and permanent injunctive relief to enforce Sections 6, 7, 8 or 9.
11. Assignment. All of the provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective heirs, executors, administrators, personal representatives, successors and assigns of the parties hereto, except that the duties and responsibilities of Executive hereunder are of a personal nature and shall not be assignable or delegable by Executive.
12. Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.
13. Amendment, Waiver. Neither Executive nor the Company may modify, amend, or waive the terms of this Agreement other than by a written instrument signed by Executive and the Company. Either partys waiver of the other partys compliance with any specific provision of this Agreement is not a waiver of any other provision of this Agreement or of any subsequent breach by such party of a provision of this Agreement. No delay on the part of any party in exercising any right, power or privilege hereunder will operate as a waiver thereof.
14. Notices. Any and all notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be effective when delivered in person, consigned to a reputable national courier service or deposited in the United States mail, postage prepaid, registered or certified, and addressed to Executive at Executives last known address on the books of the Company or, in the case of the Company, at its principal place of business, attention of the Manager of the Company, or to such other address as either party may specify by notice to the other actually received.
15. Entire Agreement. This Agreement constitutes the entire agreement between the parties and supersedes and terminates all prior communications, agreements and understandings, written or oral, with respect to the terms and conditions of Executives employment with the Company, including, without limitation, the Executive Employment Agreement between Executive and the Company dated July 20, 2016, provided that any outstanding Company equity awards shall remain subject to the applicable equity award agreement with only the specific modifications set forth herein. By entering into this Agreement, Executive certifies and acknowledges that Executive has carefully read all of the provisions of this Agreement, and that Executive voluntarily and knowingly enters into said Agreement.
16. Advice of Counsel and Construction. The parties acknowledge that all parties to this Agreement have been represented by counsel, or had the opportunity to be represented by counsel of their choice. Accordingly, the rule of construction of contract language against the drafting party is hereby waived by all parties. Additionally, neither the drafting history nor the negotiating history of this Agreement may be used or referred to in connection with the construction or interpretation of this Agreement.
17. Governing Law. This is a Maryland contract and shall be construed and enforced under and be governed in all respects by the laws of the State of Maryland, without regard to the conflict of laws principles thereof.
8
18. Effect of Excise Tax and Limit on Golden Parachute Payments.
(a) Contingent Reduction of Parachute Payments. If there is a change in ownership or control of the Company that would cause any payment or distribution by the Company or any of its subsidiaries or any other person or entity to the Executive or for the Executives benefit (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise) (each, a Payment, and collectively, the Payments) to be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code (the Code) (such excise tax, together with any interest or penalties incurred by the Executive with respect to such excise tax, the Excise Tax), then the Executive will receive the greatest of the following, whichever gives the Executive the highest net after-tax amount (after taking into account federal, state, local and social security taxes): (1) the Payments or (2) one dollar less than the amount of the Payments that would subject the Executive to the Excise Tax (the Safe Harbor Amount). If a reduction in the Payments is necessary so that the Payments equal the Safe Harbor Amount, then the reduction will be determined in a manner which has the least economic cost to the Executive and, to the extent the economic cost is equivalent, will be reduced in the inverse order of when payment would have been made to the Executive, until the reduction is achieved. Any reductions pursuant to this Section shall be made in a manner intended to be consistent with the requirements of Section 409A of the Code and the Department of Treasury Regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidelines that may be issued after the Commencement Date (Section 409A).
(b) Determination of the Payments. All determinations required to be made under this Section 9, including whether and when the Safe Harbor Amount is required and the amount of the reduction of the Payments and the assumptions to be utilized in arriving at such determination, shall be made by a certified public accounting firm or national law firm designated by Company (the Accounting Firm) which shall provide detailed supporting calculations both to the Company and the Executive within fifteen (15) business days of the receipt of notice from the Executive that there has been a Payment, or such earlier time as is requested by the Company. All fees and expenses of the Accounting Firm shall be borne solely by the Company. Any determination by the Accounting Firm shall be binding upon the Company and the Executive. The Executive shall cooperate with any reasonable requests by the Company in connection with any contests or disputes with the Internal Revenue Service in connection with the Excise Tax.
(c) Adjustments. As a result of the uncertainty in the application of Section 4999 of the Code at the time of a determination hereunder, it is possible that Payments will be made which should not have been made under clause (a) of this Section 18 (Overpayment) or that additional Payments which are not made pursuant to clause (a) of this Section 18 should have been made (Underpayment). In the event that there is a final determination by the Internal Revenue Service, or a final determination by a court of competent jurisdiction, that an Overpayment has been made, any such Overpayment shall be treated for all purposes as a loan to the Executive which the Executive shall repay to Company together with interest at the applicable Federal rate provided in Section 7872(f)(2) of the Code. In the event that there is a final determination by the Internal Revenue Service or a court of competent jurisdiction or a change in the provisions of the Code or regulations pursuant to which an Underpayment arises under this Agreement, any such Underpayment shall be promptly paid by Company to or for the benefit of the Executive, together with interest at the applicable Federal rate provided in Section 7872(f)(2) of the Code.
(d) Consultation. The Company shall consult with the Executive in good faith regarding the implementation of the provisions of this Section 18 and the application of Sections 4999 and 409A of the Code; provided, that neither the Company nor any of its subsidiaries, employees or representatives shall have any liability to the Executive with respect thereto.
9
IN WITNESS WHEREOF, this Agreement has been executed by the Company, by its duly authorized representative, and by Executive, as of the date first above written.
IronNet Cybersecurity, Inc. | ||||||||
By: | /s/ William Welch |
Date: | 9/30/2019 | |||||
Name: William Welch Title: Co-CEO |
||||||||
Executive | ||||||||
By: | /s/ Donald Closser |
Date: | 9/27/2019 |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of IronNet, Inc. of our report dated May 14, 2021, except for the effects of the Merger Agreement and Reverse Recapitalization discussed in Note 1 to the consolidated financial statements, as to which the date is March 10, 2022, relating to the financial statements of IronNet Cybersecurity, Inc., which appears in this Registration Statement. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ PricewaterhouseCoopers LLP |
Baltimore, Maryland |
March 10, 2022 |
Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
IronNet, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate | Amount of Registration Fee | |||||||||
Fees to Be Paid | Equity | Common stock, $0.0001 par value per share | 457(c) | 48,503,325 | $4.41(2) | $213,899,663.25 | $0.0000927 | $19,828.50 | ||||||||
Total Offering Amounts |
$213,899,663.25 | $19,828.50 | ||||||||||||||
Total Fees Previously Paid | | | ||||||||||||||
Total Fee Offsets | | | ||||||||||||||
Net Fee Due | $213,899,663.25 | $19,828.50 |
(1) | Consists of shares of common stock that are available to be issued and sold by the registrant to the selling stockholder named herein from time to time at the registrants election pursuant to a common stock purchase agreement, dated as of February 11, 2022, between the registrant and the selling stockholder, subject to satisfaction of the conditions set forth therein. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the registrant is also registering such additional indeterminate number of shares of common stock as may become issuable as a result of stock splits or stock dividends. |
(2) | Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c) under the Securities Act. The price per share and aggregate offering price are based on the average of the high and low prices of the Registrants common stock on March 7, 2022, as reported on the New York Stock Exchange. |
Table 2: Fee Offset Claims and Sources
N/A
Table 3: Combined Prospectuses
N/A